Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-22-3p CDH1 -0.51 0 0.99 0 MirTarget -0.36 0.00087 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL PROLIFERATION 162 1496 3.422e-74 1.592e-70
2 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 168 1672 2.39e-72 5.56e-69
3 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 149 1395 1.367e-66 2.121e-63
4 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 136 1142 4.841e-66 5.632e-63
5 REGULATION OF CELL DIFFERENTIATION 151 1492 2.257e-64 2.101e-61
6 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 161 1848 6.837e-60 5.302e-57
7 REGULATION OF CELL DEATH 141 1472 1.576e-56 9.542e-54
8 TISSUE DEVELOPMENT 143 1518 1.641e-56 9.542e-54
9 RESPONSE TO OXYGEN CONTAINING COMPOUND 133 1381 3.205e-53 1.657e-50
10 CARDIOVASCULAR SYSTEM DEVELOPMENT 103 788 9.495e-53 4.017e-50
11 CIRCULATORY SYSTEM DEVELOPMENT 103 788 9.495e-53 4.017e-50
12 RESPONSE TO ENDOGENOUS STIMULUS 135 1450 2.357e-52 9.138e-50
13 POSITIVE REGULATION OF CELL DIFFERENTIATION 104 823 7.439e-52 2.663e-49
14 VASCULATURE DEVELOPMENT 82 469 1.317e-51 4.37e-49
15 CELL DEVELOPMENT 133 1426 1.409e-51 4.37e-49
16 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 113 1021 1.253e-50 3.644e-48
17 REGULATION OF CELLULAR COMPONENT MOVEMENT 99 771 7.25e-50 1.984e-47
18 POSITIVE REGULATION OF GENE EXPRESSION 142 1733 1.506e-48 3.892e-46
19 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 144 1805 6.682e-48 1.636e-45
20 POSITIVE REGULATION OF RESPONSE TO STIMULUS 146 1929 7.665e-46 1.783e-43
21 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 105 1008 2.662e-44 5.898e-42
22 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 104 1004 1.262e-43 2.668e-41
23 BLOOD VESSEL MORPHOGENESIS 67 364 1.655e-43 3.347e-41
24 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 102 983 8.403e-43 1.629e-40
25 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 136 1784 1.248e-42 2.323e-40
26 POSITIVE REGULATION OF CELL COMMUNICATION 125 1532 7.052e-42 1.262e-39
27 RESPONSE TO EXTERNAL STIMULUS 135 1821 6.45e-41 1.112e-38
28 NEGATIVE REGULATION OF CELL DEATH 93 872 8.052e-40 1.338e-37
29 POSITIVE REGULATION OF CELL PROLIFERATION 90 814 9.534e-40 1.53e-37
30 REGULATION OF PHOSPHORUS METABOLIC PROCESS 125 1618 2.178e-39 3.379e-37
31 BIOLOGICAL ADHESION 100 1032 2.789e-39 4.187e-37
32 RESPONSE TO HORMONE 93 893 5.823e-39 8.468e-37
33 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 88 801 1.311e-38 1.848e-36
34 RESPONSE TO LIPID 92 888 2.445e-38 3.345e-36
35 REGULATION OF PROTEIN MODIFICATION PROCESS 127 1710 2.746e-38 3.651e-36
36 NEGATIVE REGULATION OF CELL PROLIFERATION 79 643 4.882e-38 6.309e-36
37 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 87 799 7.525e-38 9.463e-36
38 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 94 957 2.755e-37 3.373e-35
39 RESPONSE TO ORGANIC CYCLIC COMPOUND 92 917 3.355e-37 4.003e-35
40 REGULATION OF VASCULATURE DEVELOPMENT 51 233 4.577e-37 5.324e-35
41 EPITHELIUM DEVELOPMENT 93 945 6.131e-37 6.634e-35
42 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 123 1656 5.907e-37 6.634e-35
43 ORGAN MORPHOGENESIS 88 841 6.112e-37 6.634e-35
44 EMBRYO DEVELOPMENT 89 894 1.131e-35 1.196e-33
45 REGULATION OF MAPK CASCADE 76 660 1.323e-34 1.368e-32
46 LOCOMOTION 97 1114 3.773e-34 3.735e-32
47 NEUROGENESIS 109 1402 3.698e-34 3.735e-32
48 ANGIOGENESIS 53 293 5.007e-34 4.853e-32
49 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 107 1360 6.097e-34 5.789e-32
50 RESPONSE TO GROWTH FACTOR 64 475 4.052e-33 3.771e-31
51 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 111 1492 4.294e-33 3.918e-31
52 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 91 1036 3.134e-32 2.752e-30
53 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 91 1036 3.134e-32 2.752e-30
54 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 101 1275 3.684e-32 3.174e-30
55 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 77 740 4.955e-32 4.192e-30
56 RESPONSE TO ABIOTIC STIMULUS 90 1024 7.005e-32 5.82e-30
57 TUBE DEVELOPMENT 67 552 7.39e-32 6.033e-30
58 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 83 876 1.236e-31 9.916e-30
59 EMBRYONIC MORPHOGENESIS 66 539 1.303e-31 1.027e-29
60 POSITIVE REGULATION OF CELL DEATH 69 605 4.069e-31 3.156e-29
61 IMMUNE SYSTEM PROCESS 126 1984 4.204e-31 3.207e-29
62 NEGATIVE REGULATION OF CELL COMMUNICATION 96 1192 4.756e-31 3.569e-29
63 REGULATION OF CELL DEVELOPMENT 80 836 9.276e-31 6.851e-29
64 RESPONSE TO NITROGEN COMPOUND 81 859 1.049e-30 7.625e-29
65 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 93 1135 1.309e-30 9.369e-29
66 REGULATION OF EPITHELIAL CELL PROLIFERATION 49 285 2.008e-30 1.416e-28
67 CELL MOTILITY 79 835 4.99e-30 3.414e-28
68 LOCALIZATION OF CELL 79 835 4.99e-30 3.414e-28
69 POSITIVE REGULATION OF LOCOMOTION 57 420 1.112e-29 7.498e-28
70 IMMUNE SYSTEM DEVELOPMENT 66 582 1.304e-29 8.671e-28
71 EMBRYONIC ORGAN DEVELOPMENT 56 406 1.551e-29 1.017e-27
72 MORPHOGENESIS OF AN EPITHELIUM 55 400 6.049e-29 3.909e-27
73 POSITIVE REGULATION OF CELL DEVELOPMENT 59 472 9.385e-29 5.982e-27
74 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 104 1517 6.62e-28 4.163e-26
75 RESPONSE TO ALCOHOL 51 362 2.207e-27 1.369e-25
76 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 89 1152 2.277e-27 1.394e-25
77 RESPONSE TO PEPTIDE 53 404 6.737e-27 4.071e-25
78 TUBE MORPHOGENESIS 48 323 7.268e-27 4.336e-25
79 UROGENITAL SYSTEM DEVELOPMENT 46 299 1.94e-26 1.143e-24
80 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 67 689 4.124e-26 2.398e-24
81 SKELETAL SYSTEM DEVELOPMENT 55 455 4.274e-26 2.455e-24
82 NEGATIVE REGULATION OF CELL DIFFERENTIATION 63 609 4.945e-26 2.806e-24
83 TISSUE MORPHOGENESIS 59 533 6.248e-26 3.503e-24
84 REGULATION OF GROWTH 64 633 6.928e-26 3.837e-24
85 REGULATION OF IMMUNE SYSTEM PROCESS 96 1403 1.417e-25 7.757e-24
86 NEGATIVE REGULATION OF GENE EXPRESSION 98 1493 9.185e-25 4.969e-23
87 HEART DEVELOPMENT 54 466 9.872e-25 5.28e-23
88 REGULATION OF RESPONSE TO STRESS 97 1468 1.033e-24 5.459e-23
89 POSITIVE REGULATION OF MOLECULAR FUNCTION 108 1791 1.968e-24 1.029e-22
90 CELLULAR RESPONSE TO HORMONE STIMULUS 58 552 2.471e-24 1.273e-22
91 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 56 513 2.491e-24 1.273e-22
92 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 58 554 2.971e-24 1.503e-22
93 NEGATIVE REGULATION OF PHOSPHORYLATION 51 422 3.116e-24 1.559e-22
94 RESPONSE TO STEROID HORMONE 55 497 3.403e-24 1.684e-22
95 REPRODUCTIVE SYSTEM DEVELOPMENT 50 408 4.791e-24 2.347e-22
96 RESPONSE TO WOUNDING 58 563 6.745e-24 3.269e-22
97 NEGATIVE REGULATION OF LOCOMOTION 41 263 6.993e-24 3.355e-22
98 RESPONSE TO OXYGEN LEVELS 44 311 8.482e-24 4.027e-22
99 REGULATION OF CELL ADHESION 61 629 1.002e-23 4.711e-22
100 CELL ACTIVATION 58 568 1.056e-23 4.897e-22
101 CELL PROLIFERATION 63 672 1.063e-23 4.897e-22
102 EPITHELIAL CELL DIFFERENTIATION 54 495 1.823e-23 8.318e-22
103 RESPONSE TO ACID CHEMICAL 44 319 2.426e-23 1.096e-21
104 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 44 321 3.139e-23 1.404e-21
105 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 38 229 3.334e-23 1.478e-21
106 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 56 541 3.437e-23 1.495e-21
107 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 56 541 3.437e-23 1.495e-21
108 REGULATION OF KINASE ACTIVITY 67 776 3.583e-23 1.543e-21
109 LEUKOCYTE DIFFERENTIATION 42 292 4.857e-23 2.073e-21
110 GLAND DEVELOPMENT 48 395 5.955e-23 2.519e-21
111 CELLULAR COMPONENT MORPHOGENESIS 72 900 6.206e-23 2.602e-21
112 LEUKOCYTE ACTIVATION 49 414 6.62e-23 2.75e-21
113 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 73 926 7.108e-23 2.927e-21
114 REGULATION OF EPITHELIAL CELL MIGRATION 33 166 7.257e-23 2.962e-21
115 REGULATION OF NEURON DIFFERENTIATION 56 554 1.097e-22 4.439e-21
116 REGULATION OF ERK1 AND ERK2 CASCADE 38 238 1.385e-22 5.556e-21
117 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 65 750 1.421e-22 5.651e-21
118 POSITIVE REGULATION OF MAPK CASCADE 51 470 4.322e-22 1.691e-20
119 MUSCLE STRUCTURE DEVELOPMENT 49 432 4.324e-22 1.691e-20
120 RESPONSE TO CORTICOSTEROID 33 176 5.084e-22 1.971e-20
121 STEM CELL DIFFERENTIATION 34 190 5.745e-22 2.209e-20
122 NEURON DIFFERENTIATION 69 874 1.177e-21 4.489e-20
123 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 50 465 1.7e-21 6.429e-20
124 REGULATION OF RESPONSE TO WOUNDING 47 413 2.795e-21 1.049e-19
125 LYMPHOCYTE ACTIVATION 43 342 3.157e-21 1.175e-19
126 CENTRAL NERVOUS SYSTEM DEVELOPMENT 68 872 4.75e-21 1.754e-19
127 REGULATION OF TRANSFERASE ACTIVITY 71 946 4.99e-21 1.828e-19
128 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 56 602 5.986e-21 2.176e-19
129 CONNECTIVE TISSUE DEVELOPMENT 33 194 1.229e-20 4.432e-19
130 MORPHOGENESIS OF A BRANCHING STRUCTURE 31 167 1.281e-20 4.585e-19
131 EXTRACELLULAR STRUCTURE ORGANIZATION 40 304 1.54e-20 5.47e-19
132 RESPONSE TO DRUG 47 431 1.665e-20 5.869e-19
133 POSITIVE REGULATION OF NEURON DIFFERENTIATION 40 306 1.963e-20 6.867e-19
134 PATTERN SPECIFICATION PROCESS 46 418 3.013e-20 1.046e-18
135 REPRODUCTION 83 1297 3.735e-20 1.287e-18
136 RESPONSE TO INORGANIC SUBSTANCE 49 479 3.766e-20 1.288e-18
137 REGULATION OF OSTEOBLAST DIFFERENTIATION 26 112 4.531e-20 1.539e-18
138 REGENERATION 30 161 4.851e-20 1.635e-18
139 CELLULAR RESPONSE TO NITROGEN COMPOUND 50 505 6.225e-20 2.084e-18
140 REGULATION OF ENDOTHELIAL CELL MIGRATION 26 114 7.335e-20 2.438e-18
141 GROWTH 45 410 8.845e-20 2.919e-18
142 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 55 616 9.276e-20 3.04e-18
143 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 33 207 9.871e-20 3.212e-18
144 RESPONSE TO MECHANICAL STIMULUS 33 210 1.561e-19 5.043e-18
145 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 46 437 1.827e-19 5.852e-18
146 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 74 1087 1.836e-19 5.852e-18
147 CELLULAR RESPONSE TO LIPID 47 457 1.867e-19 5.911e-18
148 INTRACELLULAR SIGNAL TRANSDUCTION 91 1572 3.222e-19 1.013e-17
149 REGULATION OF CELL ACTIVATION 48 484 3.397e-19 1.061e-17
150 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 27 133 3.601e-19 1.117e-17
151 RESPONSE TO BACTERIUM 50 528 4.197e-19 1.293e-17
152 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 47 470 5.86e-19 1.794e-17
153 POSITIVE REGULATION OF TRANSPORT 67 936 9.134e-19 2.778e-17
154 REGULATION OF OSSIFICATION 30 178 9.527e-19 2.878e-17
155 SINGLE ORGANISM CELL ADHESION 46 459 1.305e-18 3.895e-17
156 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 64 867 1.306e-18 3.895e-17
157 RESPONSE TO EXTRACELLULAR STIMULUS 45 441 1.571e-18 4.656e-17
158 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 28 154 1.738e-18 5.117e-17
159 RESPONSE TO KETONE 30 182 1.825e-18 5.342e-17
160 NEGATIVE REGULATION OF MOLECULAR FUNCTION 72 1079 1.848e-18 5.373e-17
161 EMBRYONIC ORGAN MORPHOGENESIS 36 279 2.634e-18 7.614e-17
162 REGULATION OF DEFENSE RESPONSE 59 759 3.034e-18 8.713e-17
163 OSSIFICATION 34 251 5.155e-18 1.471e-16
164 VASCULOGENESIS 19 59 5.977e-18 1.696e-16
165 MESENCHYME DEVELOPMENT 30 190 6.369e-18 1.796e-16
166 HOMEOSTATIC PROCESS 80 1337 1.092e-17 3.06e-16
167 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 27 152 1.341e-17 3.736e-16
168 IN UTERO EMBRYONIC DEVELOPMENT 37 311 1.353e-17 3.746e-16
169 REGULATION OF HEMOPOIESIS 37 314 1.863e-17 5.129e-16
170 RESPONSE TO OXIDATIVE STRESS 39 352 2.067e-17 5.658e-16
171 AGING 34 264 2.524e-17 6.869e-16
172 REGULATION OF BINDING 35 283 3.083e-17 8.33e-16
173 NEGATIVE REGULATION OF NEURON DEATH 28 171 3.097e-17 8.33e-16
174 CELL CELL ADHESION 51 608 3.168e-17 8.472e-16
175 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 25 131 3.659e-17 9.728e-16
176 CARTILAGE DEVELOPMENT 26 147 6.044e-17 1.598e-15
177 TAXIS 44 464 6.185e-17 1.626e-15
178 REGIONALIZATION 36 311 9.176e-17 2.399e-15
179 LYMPHOCYTE DIFFERENTIATION 30 209 9.721e-17 2.527e-15
180 REGULATION OF CELL PROJECTION ORGANIZATION 48 558 1.083e-16 2.8e-15
181 CELL FATE COMMITMENT 31 227 1.254e-16 3.223e-15
182 REGULATION OF CYTOKINE PRODUCTION 48 563 1.541e-16 3.919e-15
183 POSITIVE REGULATION OF CATALYTIC ACTIVITY 84 1518 1.538e-16 3.919e-15
184 RESPIRATORY SYSTEM DEVELOPMENT 29 197 1.604e-16 4.056e-15
185 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 45 498 1.67e-16 4.201e-15
186 REGULATION OF LIPID METABOLIC PROCESS 34 282 1.953e-16 4.885e-15
187 REGULATION OF MUSCLE TISSUE DEVELOPMENT 22 103 2.383e-16 5.929e-15
188 RESPONSE TO ESTROGEN 30 218 3.185e-16 7.882e-15
189 MUSCLE CELL DIFFERENTIATION 31 237 4.329e-16 1.066e-14
190 WOUND HEALING 43 470 5.248e-16 1.285e-14
191 SENSORY ORGAN DEVELOPMENT 44 493 5.842e-16 1.423e-14
192 DEVELOPMENTAL GROWTH 36 333 8.154e-16 1.976e-14
193 ARTERY DEVELOPMENT 19 75 9.012e-16 2.173e-14
194 RHYTHMIC PROCESS 34 298 1.054e-15 2.527e-14
195 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 21 98 1.075e-15 2.565e-14
196 POSITIVE REGULATION OF KINASE ACTIVITY 43 482 1.3e-15 3.086e-14
197 REGULATION OF CELL CELL ADHESION 38 380 1.634e-15 3.86e-14
198 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 21 100 1.661e-15 3.885e-14
199 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 21 100 1.661e-15 3.885e-14
200 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 34 303 1.743e-15 4.055e-14
201 REGULATION OF NEURON PROJECTION DEVELOPMENT 39 408 3.07e-15 7.106e-14
202 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 21 103 3.131e-15 7.177e-14
203 REGULATION OF MUSCLE ORGAN DEVELOPMENT 21 103 3.131e-15 7.177e-14
204 HEAD DEVELOPMENT 52 709 4.038e-15 9.21e-14
205 ARTERY MORPHOGENESIS 16 51 4.097e-15 9.299e-14
206 REGULATION OF INFLAMMATORY RESPONSE 33 294 4.561e-15 1.03e-13
207 CHEMICAL HOMEOSTASIS 58 874 7.554e-15 1.698e-13
208 MESENCHYMAL CELL DIFFERENTIATION 23 134 7.68e-15 1.718e-13
209 HEART MORPHOGENESIS 28 212 9.279e-15 2.066e-13
210 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 52 724 9.419e-15 2.087e-13
211 ENDOCRINE SYSTEM DEVELOPMENT 22 123 1.222e-14 2.694e-13
212 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 29 232 1.321e-14 2.898e-13
213 REGULATION OF CELLULAR LOCALIZATION 72 1277 1.331e-14 2.908e-13
214 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 36 365 1.437e-14 3.124e-13
215 REGULATION OF WNT SIGNALING PATHWAY 33 310 2.131e-14 4.612e-13
216 RESPONSE TO CYTOKINE 51 714 2.169e-14 4.673e-13
217 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 47 616 2.204e-14 4.726e-13
218 POSITIVE REGULATION OF CELL ACTIVATION 33 311 2.339e-14 4.992e-13
219 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 39 437 2.921e-14 6.205e-13
220 RESPONSE TO INSULIN 27 205 3.023e-14 6.394e-13
221 MYELOID CELL DIFFERENTIATION 26 189 3.204e-14 6.745e-13
222 REGULATION OF CELL MORPHOGENESIS 44 552 3.424e-14 7.176e-13
223 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 23 144 3.841e-14 8.014e-13
224 REGULATION OF MAP KINASE ACTIVITY 33 319 4.854e-14 1.008e-12
225 RESPONSE TO BIOTIC STIMULUS 57 886 4.966e-14 1.027e-12
226 RESPONSE TO ESTRADIOL 23 146 5.213e-14 1.073e-12
227 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 27 211 6.19e-14 1.269e-12
228 CELLULAR RESPONSE TO STRESS 80 1565 7.28e-14 1.486e-12
229 NEURON DEVELOPMENT 49 687 7.774e-14 1.58e-12
230 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 27 213 7.815e-14 1.581e-12
231 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 15 51 8.803e-14 1.773e-12
232 REGULATION OF LEUKOCYTE DIFFERENTIATION 28 232 9.317e-14 1.869e-12
233 REGULATION OF NEURON DEATH 29 252 1.15e-13 2.296e-12
234 IMMUNE RESPONSE 64 1100 1.202e-13 2.39e-12
235 POSITIVE REGULATION OF OSSIFICATION 18 84 1.222e-13 2.42e-12
236 REGULATION OF MUSCLE CELL DIFFERENTIATION 23 152 1.265e-13 2.487e-12
237 REGULATION OF TRANSPORT 87 1804 1.267e-13 2.487e-12
238 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 54 829 1.507e-13 2.946e-12
239 CELLULAR RESPONSE TO PEPTIDE 30 274 1.611e-13 3.123e-12
240 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 30 274 1.611e-13 3.123e-12
241 MUSCLE TISSUE DEVELOPMENT 30 275 1.773e-13 3.424e-12
242 POSITIVE REGULATION OF CELL ADHESION 35 376 1.896e-13 3.646e-12
243 SYSTEM PROCESS 86 1785 1.918e-13 3.674e-12
244 PROTEIN PHOSPHORYLATION 58 944 2.056e-13 3.922e-12
245 MUSCLE ORGAN DEVELOPMENT 30 277 2.147e-13 4.078e-12
246 FOREBRAIN DEVELOPMENT 34 357 2.207e-13 4.175e-12
247 REGULATION OF PROTEIN LOCALIZATION 58 950 2.684e-13 5.057e-12
248 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 21 128 2.916e-13 5.472e-12
249 GLIOGENESIS 24 175 3.401e-13 6.355e-12
250 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 20 115 3.465e-13 6.449e-12
251 CELLULAR RESPONSE TO EXTERNAL STIMULUS 29 264 3.806e-13 7.055e-12
252 NEURON PROJECTION DEVELOPMENT 42 545 4.213e-13 7.78e-12
253 ANTERIOR POSTERIOR PATTERN SPECIFICATION 25 194 4.572e-13 8.409e-12
254 CELL CHEMOTAXIS 23 162 5.061e-13 9.234e-12
255 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 23 162 5.061e-13 9.234e-12
256 REGULATION OF HOMOTYPIC CELL CELL ADHESION 31 307 5.578e-13 1.014e-11
257 NEGATIVE REGULATION OF KINASE ACTIVITY 28 250 6.06e-13 1.097e-11
258 DIGESTIVE SYSTEM DEVELOPMENT 22 148 6.306e-13 1.137e-11
259 REGULATION OF CELLULAR PROTEIN LOCALIZATION 42 552 6.436e-13 1.156e-11
260 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 25 197 6.498e-13 1.163e-11
261 CELL SUBSTRATE ADHESION 23 164 6.593e-13 1.175e-11
262 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 17 80 6.844e-13 1.215e-11
263 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 21 135 8.572e-13 1.517e-11
264 RESPONSE TO METAL ION 32 333 9.032e-13 1.592e-11
265 REGULATION OF MYELOID CELL DIFFERENTIATION 24 183 9.19e-13 1.614e-11
266 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 26 218 9.62e-13 1.683e-11
267 SKELETAL SYSTEM MORPHOGENESIS 25 201 1.028e-12 1.791e-11
268 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 15 60 1.235e-12 2.145e-11
269 CELL CELL SIGNALING 50 767 1.276e-12 2.207e-11
270 ORGAN REGENERATION 17 83 1.297e-12 2.235e-11
271 PEPTIDYL TYROSINE MODIFICATION 24 186 1.316e-12 2.259e-11
272 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 21 138 1.333e-12 2.28e-11
273 GASTRULATION 22 155 1.646e-12 2.806e-11
274 REGULATION OF ORGAN MORPHOGENESIS 27 242 1.738e-12 2.951e-11
275 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 23 172 1.828e-12 3.093e-11
276 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 22 156 1.88e-12 3.169e-11
277 REGULATION OF IMMUNE RESPONSE 53 858 2.05e-12 3.431e-11
278 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 20 126 2.048e-12 3.431e-11
279 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 14 52 2.311e-12 3.841e-11
280 CIRCULATORY SYSTEM PROCESS 33 366 2.304e-12 3.841e-11
281 RESPONSE TO NUTRIENT 24 191 2.356e-12 3.888e-11
282 RESPONSE TO REACTIVE OXYGEN SPECIES 24 191 2.356e-12 3.888e-11
283 REGULATION OF HYDROLASE ACTIVITY 69 1327 2.392e-12 3.92e-11
284 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 17 86 2.391e-12 3.92e-11
285 OVULATION CYCLE 19 113 2.546e-12 4.157e-11
286 CELLULAR RESPONSE TO ACID CHEMICAL 23 175 2.64e-12 4.295e-11
287 REGULATION OF CELL GROWTH 34 391 2.929e-12 4.749e-11
288 DEVELOPMENTAL MATURATION 24 193 2.959e-12 4.78e-11
289 NEGATIVE REGULATION OF DEFENSE RESPONSE 21 144 3.112e-12 5.011e-11
290 REGULATION OF SYSTEM PROCESS 39 507 3.224e-12 5.174e-11
291 NEPHRON DEVELOPMENT 19 115 3.521e-12 5.631e-11
292 NEGATIVE REGULATION OF MAPK CASCADE 21 145 3.57e-12 5.689e-11
293 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 33 372 3.598e-12 5.714e-11
294 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 29 289 3.74e-12 5.919e-11
295 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 26 233 4.508e-12 7.111e-11
296 MAMMARY GLAND DEVELOPMENT 19 117 4.837e-12 7.604e-11
297 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 15 67 7.021e-12 1.1e-10
298 REGULATION OF SECRETION 46 699 7.922e-12 1.237e-10
299 LEUKOCYTE MIGRATION 27 259 8.673e-12 1.35e-10
300 GLIAL CELL DIFFERENTIATION 20 136 8.799e-12 1.365e-10
301 REGULATION OF PROTEIN KINASE B SIGNALING 19 121 8.952e-12 1.384e-10
302 REGULATION OF DNA BINDING 17 93 9.055e-12 1.395e-10
303 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 19 122 1.04e-11 1.597e-10
304 PLACENTA DEVELOPMENT 20 138 1.159e-11 1.774e-10
305 REGULATION OF LEUKOCYTE PROLIFERATION 24 206 1.214e-11 1.852e-10
306 CELLULAR RESPONSE TO ABIOTIC STIMULUS 27 263 1.242e-11 1.888e-10
307 CELL PROJECTION ORGANIZATION 53 902 1.371e-11 2.077e-10
308 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 45 684 1.375e-11 2.077e-10
309 EYE DEVELOPMENT 30 326 1.425e-11 2.146e-10
310 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 23 190 1.484e-11 2.227e-10
311 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 21 156 1.5e-11 2.238e-10
312 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 21 156 1.5e-11 2.238e-10
313 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 12 39 1.516e-11 2.253e-10
314 CARDIOCYTE DIFFERENTIATION 17 96 1.544e-11 2.288e-10
315 KIDNEY EPITHELIUM DEVELOPMENT 19 125 1.617e-11 2.382e-10
316 SEX DIFFERENTIATION 27 266 1.617e-11 2.382e-10
317 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 13 49 1.75e-11 2.569e-10
318 REGULATION OF NEURON APOPTOTIC PROCESS 23 192 1.844e-11 2.698e-10
319 REGULATION OF WOUND HEALING 19 126 1.868e-11 2.707e-10
320 OSTEOBLAST DIFFERENTIATION 19 126 1.868e-11 2.707e-10
321 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 31 351 1.861e-11 2.707e-10
322 RESPONSE TO PURINE CONTAINING COMPOUND 21 158 1.922e-11 2.777e-10
323 REGULATION OF DEVELOPMENTAL GROWTH 28 289 2.06e-11 2.968e-10
324 CELLULAR RESPONSE TO OXYGEN LEVELS 20 143 2.262e-11 3.249e-10
325 CELL DEATH 56 1001 2.315e-11 3.315e-10
326 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 17 99 2.582e-11 3.673e-10
327 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 17 99 2.582e-11 3.673e-10
328 REGULATION OF HOMEOSTATIC PROCESS 35 447 2.697e-11 3.826e-10
329 NOTCH SIGNALING PATHWAY 18 114 2.888e-11 4.085e-10
330 REGULATION OF CELL CYCLE 54 949 2.908e-11 4.101e-10
331 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 17 100 3.051e-11 4.289e-10
332 CELLULAR RESPONSE TO ALCOHOL 18 115 3.359e-11 4.707e-10
333 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 16 87 3.385e-11 4.729e-10
334 POSITIVE REGULATION OF HEMOPOIESIS 21 163 3.51e-11 4.875e-10
335 LEUKOCYTE CELL CELL ADHESION 26 255 3.504e-11 4.875e-10
336 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 25 236 3.676e-11 5.091e-10
337 REGULATION OF CARTILAGE DEVELOPMENT 14 63 3.957e-11 5.464e-10
338 REGULATION OF BODY FLUID LEVELS 37 506 5.184e-11 7.131e-10
339 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 13 53 5.195e-11 7.131e-10
340 REGULATION OF CELLULAR COMPONENT BIOGENESIS 47 767 5.371e-11 7.35e-10
341 ENDOTHELIUM DEVELOPMENT 16 90 5.79e-11 7.901e-10
342 RESPONSE TO FLUID SHEAR STRESS 11 34 5.846e-11 7.954e-10
343 RESPONSE TO CARBOHYDRATE 21 168 6.268e-11 8.503e-10
344 EPITHELIAL CELL DEVELOPMENT 22 186 6.554e-11 8.866e-10
345 REGULATION OF FAT CELL DIFFERENTIATION 17 106 7.98e-11 1.076e-09
346 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 18 121 8.042e-11 1.082e-09
347 AMEBOIDAL TYPE CELL MIGRATION 20 154 8.939e-11 1.199e-09
348 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 21 172 9.816e-11 1.313e-09
349 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 24 228 1.042e-10 1.389e-09
350 BONE DEVELOPMENT 20 156 1.133e-10 1.506e-09
351 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 15 81 1.264e-10 1.676e-09
352 DEFENSE RESPONSE 62 1231 1.358e-10 1.795e-09
353 CELLULAR MACROMOLECULE LOCALIZATION 62 1234 1.498e-10 1.975e-09
354 MULTI MULTICELLULAR ORGANISM PROCESS 23 213 1.54e-10 2.024e-09
355 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 29 337 1.58e-10 2.072e-09
356 REGULATION OF PROTEOLYSIS 44 711 1.699e-10 2.221e-09
357 INFLAMMATORY RESPONSE 34 454 1.73e-10 2.254e-09
358 SINGLE ORGANISM BEHAVIOR 31 384 1.802e-10 2.343e-09
359 RESPONSE TO FATTY ACID 15 83 1.817e-10 2.349e-09
360 REGULATION OF ORGANELLE ORGANIZATION 60 1178 1.813e-10 2.349e-09
361 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 23 216 2.04e-10 2.63e-09
362 MUSCLE CELL DEVELOPMENT 18 128 2.088e-10 2.683e-09
363 NEGATIVE REGULATION OF GROWTH 24 236 2.135e-10 2.736e-09
364 RESPONSE TO VITAMIN 16 98 2.192e-10 2.802e-09
365 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 20 162 2.254e-10 2.865e-09
366 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 20 162 2.254e-10 2.865e-09
367 REGULATION OF STEM CELL DIFFERENTIATION 17 113 2.26e-10 2.865e-09
368 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 12 48 2.275e-10 2.877e-09
369 POSITIVE REGULATION OF GROWTH 24 238 2.542e-10 3.205e-09
370 STEM CELL PROLIFERATION 13 60 2.791e-10 3.51e-09
371 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 23 220 2.947e-10 3.696e-09
372 SMOOTH MUSCLE CELL DIFFERENTIATION 10 30 3.168e-10 3.952e-09
373 REGULATION OF PROTEIN IMPORT 21 183 3.16e-10 3.952e-09
374 POSITIVE REGULATION OF CYTOKINE PRODUCTION 30 370 3.223e-10 4.01e-09
375 CELLULAR RESPONSE TO KETONE 14 73 3.232e-10 4.01e-09
376 PHOSPHORYLATION 61 1228 3.38e-10 4.182e-09
377 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 16 101 3.492e-10 4.301e-09
378 BEHAVIOR 36 516 3.503e-10 4.301e-09
379 CELLULAR RESPONSE TO OXIDATIVE STRESS 21 184 3.499e-10 4.301e-09
380 TISSUE REMODELING 15 87 3.641e-10 4.459e-09
381 CELL JUNCTION ORGANIZATION 21 185 3.872e-10 4.728e-09
382 POSITIVE REGULATION OF CELL CELL ADHESION 24 243 3.899e-10 4.749e-09
383 REGULATION OF CATABOLIC PROCESS 44 731 4.081e-10 4.958e-09
384 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 13 62 4.32e-10 5.235e-09
385 GLUCOSE HOMEOSTASIS 20 170 5.379e-10 6.484e-09
386 CARBOHYDRATE HOMEOSTASIS 20 170 5.379e-10 6.484e-09
387 GLIAL CELL DEVELOPMENT 14 76 5.672e-10 6.802e-09
388 EXTRACELLULAR MATRIX DISASSEMBLY 14 76 5.672e-10 6.802e-09
389 REGULATION OF ACTIN FILAMENT BASED PROCESS 27 312 6.078e-10 7.27e-09
390 SKELETAL MUSCLE ORGAN DEVELOPMENT 18 137 6.501e-10 7.756e-09
391 REGULATION OF GLUCOSE METABOLIC PROCESS 16 106 7.314e-10 8.681e-09
392 FAT CELL DIFFERENTIATION 16 106 7.314e-10 8.681e-09
393 STRIATED MUSCLE CELL DIFFERENTIATION 20 173 7.355e-10 8.708e-09
394 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 13 65 8.064e-10 9.523e-09
395 RESPONSE TO ORGANOPHOSPHORUS 18 139 8.264e-10 9.734e-09
396 T CELL DIFFERENTIATION 17 123 8.78e-10 1.032e-08
397 SECRETION 38 588 9.738e-10 1.141e-08
398 EAR DEVELOPMENT 21 195 1.027e-09 1.2e-08
399 REGULATION OF PROTEIN SECRETION 30 389 1.066e-09 1.243e-08
400 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 35 514 1.185e-09 1.378e-08
401 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 21 197 1.238e-09 1.437e-08
402 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 29 368 1.242e-09 1.437e-08
403 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 12 55 1.254e-09 1.448e-08
404 CANONICAL WNT SIGNALING PATHWAY 15 95 1.31e-09 1.508e-08
405 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 20 179 1.348e-09 1.549e-08
406 POSITIVE REGULATION OF BINDING 17 127 1.455e-09 1.664e-08
407 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 68 1.455e-09 1.664e-08
408 PROTEIN LOCALIZATION 77 1805 1.468e-09 1.674e-08
409 CARDIAC CHAMBER DEVELOPMENT 18 144 1.478e-09 1.682e-08
410 MYELOID LEUKOCYTE DIFFERENTIATION 15 96 1.523e-09 1.728e-08
411 EPITHELIAL TO MESENCHYMAL TRANSITION 12 56 1.566e-09 1.769e-08
412 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 12 56 1.566e-09 1.769e-08
413 CELLULAR RESPONSE TO BIOTIC STIMULUS 19 163 1.709e-09 1.925e-08
414 RESPONSE TO ACTIVITY 13 69 1.759e-09 1.977e-08
415 GLAND MORPHOGENESIS 15 97 1.767e-09 1.981e-08
416 CELLULAR RESPONSE TO INSULIN STIMULUS 18 146 1.852e-09 2.072e-08
417 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 17 129 1.86e-09 2.075e-08
418 REGULATION OF T CELL PROLIFERATION 18 147 2.07e-09 2.305e-08
419 NEGATIVE REGULATION OF CELL ADHESION 22 223 2.168e-09 2.408e-08
420 KIDNEY VASCULATURE DEVELOPMENT 8 19 2.226e-09 2.46e-08
421 RENAL SYSTEM VASCULATURE DEVELOPMENT 8 19 2.226e-09 2.46e-08
422 NEURON PROJECTION MORPHOGENESIS 30 402 2.311e-09 2.548e-08
423 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 10 36 2.394e-09 2.633e-08
424 REGULATION OF HORMONE LEVELS 33 478 2.556e-09 2.804e-08
425 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 14 85 2.64e-09 2.89e-08
426 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 29 381 2.751e-09 3.005e-08
427 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 12 59 2.966e-09 3.232e-08
428 ENDOTHELIAL CELL DIFFERENTIATION 13 72 3.047e-09 3.312e-08
429 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 28 360 3.23e-09 3.503e-08
430 REGULATION OF LIPID KINASE ACTIVITY 11 48 3.542e-09 3.833e-08
431 REGULATION OF SPROUTING ANGIOGENESIS 9 28 3.611e-09 3.898e-08
432 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 15 102 3.619e-09 3.898e-08
433 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 12 60 3.638e-09 3.9e-08
434 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 12 60 3.638e-09 3.9e-08
435 SECRETION BY CELL 33 486 3.861e-09 4.13e-08
436 REGULATION OF DNA METABOLIC PROCESS 27 340 3.975e-09 4.242e-08
437 REGULATION OF VESICLE MEDIATED TRANSPORT 32 462 4.153e-09 4.422e-08
438 RESPONSE TO ETHANOL 17 136 4.235e-09 4.489e-08
439 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 17 136 4.235e-09 4.489e-08
440 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 25 296 4.377e-09 4.629e-08
441 REGULATION OF INTRACELLULAR TRANSPORT 38 621 4.395e-09 4.638e-08
442 CARDIAC CHAMBER MORPHOGENESIS 15 104 4.764e-09 5.015e-08
443 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 9 29 5.14e-09 5.386e-08
444 NEURAL CREST CELL DIFFERENTIATION 13 75 5.138e-09 5.386e-08
445 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 16 121 5.319e-09 5.562e-08
446 ODONTOGENESIS 15 105 5.452e-09 5.688e-08
447 RESPONSE TO PROGESTERONE 11 50 5.639e-09 5.869e-08
448 ASTROCYTE DIFFERENTIATION 10 39 5.659e-09 5.878e-08
449 MESONEPHROS DEVELOPMENT 14 90 5.707e-09 5.914e-08
450 MULTICELLULAR ORGANISM REPRODUCTION 43 768 5.775e-09 5.971e-08
451 NEGATIVE REGULATION OF CELL DEVELOPMENT 25 303 7.031e-09 7.254e-08
452 RESPONSE TO RETINOIC ACID 15 107 7.109e-09 7.318e-08
453 REGULATION OF BMP SIGNALING PATHWAY 13 77 7.178e-09 7.373e-08
454 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 10 40 7.405e-09 7.59e-08
455 CELLULAR RESPONSE TO CYTOKINE STIMULUS 37 606 7.529e-09 7.699e-08
456 INOSITOL LIPID MEDIATED SIGNALING 16 124 7.628e-09 7.784e-08
457 REGULATION OF CELLULAR RESPONSE TO STRESS 40 691 8.088e-09 8.235e-08
458 NEPHRON EPITHELIUM DEVELOPMENT 14 93 8.843e-09 8.984e-08
459 REGULATION OF PROTEIN TARGETING 25 307 9.157e-09 9.283e-08
460 RESPONSE TO HYDROGEN PEROXIDE 15 109 9.213e-09 9.319e-08
461 FORMATION OF PRIMARY GERM LAYER 15 110 1.047e-08 1.056e-07
462 MAMMARY GLAND EPITHELIUM DEVELOPMENT 11 53 1.087e-08 1.093e-07
463 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 11 53 1.087e-08 1.093e-07
464 POSITIVE REGULATION OF HYDROLASE ACTIVITY 47 905 1.149e-08 1.152e-07
465 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 14 95 1.173e-08 1.174e-07
466 REGULATION OF HEART GROWTH 10 42 1.238e-08 1.236e-07
467 NEGATIVE REGULATION OF TRANSPORT 31 458 1.253e-08 1.249e-07
468 NEGATIVE REGULATION OF CELL CYCLE 30 433 1.28e-08 1.273e-07
469 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 9 32 1.361e-08 1.345e-07
470 ENDOCARDIAL CUSHION DEVELOPMENT 9 32 1.361e-08 1.345e-07
471 PATTERNING OF BLOOD VESSELS 9 32 1.361e-08 1.345e-07
472 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 12 67 1.365e-08 1.346e-07
473 POSITIVE REGULATION OF DNA METABOLIC PROCESS 19 185 1.418e-08 1.395e-07
474 POSITIVE REGULATION OF MAP KINASE ACTIVITY 20 207 1.677e-08 1.646e-07
475 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 16 131 1.699e-08 1.664e-07
476 POSITIVE REGULATION OF ENDOCYTOSIS 15 114 1.718e-08 1.68e-07
477 REGULATION OF PROTEIN BINDING 18 168 1.76e-08 1.717e-07
478 REGULATION OF CELL DIVISION 23 272 1.797e-08 1.749e-07
479 EMBRYONIC PLACENTA DEVELOPMENT 13 83 1.843e-08 1.79e-07
480 B CELL ACTIVATION 16 132 1.896e-08 1.838e-07
481 REGULATION OF BLOOD PRESSURE 18 169 1.932e-08 1.869e-07
482 RESPONSE TO INTERLEUKIN 1 15 115 1.938e-08 1.871e-07
483 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 8 24 1.975e-08 1.902e-07
484 OUTFLOW TRACT MORPHOGENESIS 11 56 2.007e-08 1.929e-07
485 NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 10 44 2.011e-08 1.929e-07
486 REGULATION OF PEPTIDASE ACTIVITY 28 392 2.068e-08 1.98e-07
487 RECEPTOR MEDIATED ENDOCYTOSIS 21 231 2.152e-08 2.056e-07
488 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 11 57 2.44e-08 2.326e-07
489 RESPONSE TO PROSTAGLANDIN 9 34 2.452e-08 2.328e-07
490 HEART VALVE DEVELOPMENT 9 34 2.452e-08 2.328e-07
491 LUNG MORPHOGENESIS 10 45 2.537e-08 2.399e-07
492 SPROUTING ANGIOGENESIS 10 45 2.537e-08 2.399e-07
493 PEPTIDYL AMINO ACID MODIFICATION 44 841 2.825e-08 2.666e-07
494 RESPONSE TO PROSTAGLANDIN E 8 25 2.851e-08 2.68e-07
495 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 8 25 2.851e-08 2.68e-07
496 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 11 58 2.955e-08 2.772e-07
497 REGULATION OF IMMUNE EFFECTOR PROCESS 29 424 2.986e-08 2.796e-07
498 REGULATION OF CYTOSKELETON ORGANIZATION 32 502 2.993e-08 2.797e-07
499 WNT SIGNALING PATHWAY 26 351 3.223e-08 3.005e-07
500 HOMEOSTASIS OF NUMBER OF CELLS 18 175 3.335e-08 3.103e-07
501 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 12 73 3.734e-08 3.447e-07
502 PANCREAS DEVELOPMENT 12 73 3.734e-08 3.447e-07
503 EMBRYONIC HEART TUBE DEVELOPMENT 12 73 3.734e-08 3.447e-07
504 REGULATION OF ORGAN GROWTH 12 73 3.734e-08 3.447e-07
505 REGULATION OF COAGULATION 13 88 3.803e-08 3.504e-07
506 RESPONSE TO CAMP 14 104 3.842e-08 3.519e-07
507 POSITIVE REGULATION OF PROTEIN IMPORT 14 104 3.842e-08 3.519e-07
508 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 14 104 3.842e-08 3.519e-07
509 REGULATION OF CYTOPLASMIC TRANSPORT 31 481 3.864e-08 3.532e-07
510 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 8 26 4.043e-08 3.688e-07
511 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 9 36 4.24e-08 3.846e-07
512 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 9 36 4.24e-08 3.846e-07
513 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 9 36 4.24e-08 3.846e-07
514 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 15 122 4.355e-08 3.942e-07
515 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 28 406 4.365e-08 3.944e-07
516 REGULATION OF ENDOCYTOSIS 19 199 4.641e-08 4.185e-07
517 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 16 141 4.881e-08 4.393e-07
518 DIGESTIVE TRACT MORPHOGENESIS 10 48 4.916e-08 4.408e-07
519 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 10 48 4.916e-08 4.408e-07
520 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 11 61 5.126e-08 4.587e-07
521 MULTI ORGANISM REPRODUCTIVE PROCESS 45 891 5.473e-08 4.888e-07
522 MYOBLAST DIFFERENTIATION 9 37 5.499e-08 4.892e-07
523 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 9 37 5.499e-08 4.892e-07
524 PLATELET DEGRANULATION 14 107 5.549e-08 4.928e-07
525 RESPONSE TO RADIATION 28 413 6.256e-08 5.534e-07
526 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 14 108 6.255e-08 5.534e-07
527 REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 7 19 7.057e-08 6.231e-07
528 MESENCHYME MORPHOGENESIS 9 38 7.073e-08 6.233e-07
529 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 10 50 7.437e-08 6.529e-07
530 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 10 50 7.437e-08 6.529e-07
531 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 13 93 7.475e-08 6.55e-07
532 REGULATION OF LIPID BIOSYNTHETIC PROCESS 15 128 8.334e-08 7.289e-07
533 REGULATION OF PROTEIN ACETYLATION 11 64 8.615e-08 7.521e-07
534 ANATOMICAL STRUCTURE MATURATION 9 39 9.025e-08 7.849e-07
535 TRABECULA MORPHOGENESIS 9 39 9.025e-08 7.849e-07
536 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 26 370 9.244e-08 8.001e-07
537 CELL JUNCTION ASSEMBLY 15 129 9.251e-08 8.001e-07
538 POSITIVE REGULATION OF SECRETION 26 370 9.244e-08 8.001e-07
539 REGULATION OF LIPID TRANSPORT 13 95 9.675e-08 8.338e-07
540 MALE SEX DIFFERENTIATION 16 148 9.677e-08 8.338e-07
541 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 18 188 1.006e-07 8.653e-07
542 CELLULAR RESPONSE TO RETINOIC ACID 11 65 1.018e-07 8.736e-07
543 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 1.051e-07 8.988e-07
544 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 8 29 1.051e-07 8.988e-07
545 REGULATION OF CYTOKINE SECRETION 16 149 1.063e-07 9.08e-07
546 CELLULAR RESPONSE TO MECHANICAL STIMULUS 12 80 1.071e-07 9.131e-07
547 NEGATIVE REGULATION OF BINDING 15 131 1.137e-07 9.669e-07
548 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 9 40 1.143e-07 9.705e-07
549 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 19 211 1.18e-07 1e-06
550 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 11 66 1.198e-07 1.012e-06
551 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 11 66 1.198e-07 1.012e-06
552 NEGATIVE REGULATION OF CELL GROWTH 17 170 1.214e-07 1.024e-06
553 METANEPHROS DEVELOPMENT 12 81 1.234e-07 1.038e-06
554 CELLULAR HOMEOSTASIS 37 676 1.257e-07 1.056e-06
555 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 6 13 1.271e-07 1.066e-06
556 POSITIVE REGULATION OF IMMUNE RESPONSE 33 563 1.309e-07 1.095e-06
557 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 19 213 1.37e-07 1.144e-06
558 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 8 30 1.407e-07 1.171e-06
559 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 8 30 1.407e-07 1.171e-06
560 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 9 41 1.437e-07 1.194e-06
561 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 27 404 1.444e-07 1.198e-06
562 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 16 153 1.539e-07 1.274e-06
563 FEMALE SEX DIFFERENTIATION 14 116 1.555e-07 1.286e-06
564 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 11 68 1.647e-07 1.359e-06
565 CELL CYCLE ARREST 16 154 1.685e-07 1.388e-06
566 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 135 1.696e-07 1.394e-06
567 CELLULAR CHEMICAL HOMEOSTASIS 33 570 1.74e-07 1.428e-06
568 POSITIVE REGULATION OF DNA BINDING 9 42 1.796e-07 1.468e-06
569 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 9 42 1.796e-07 1.468e-06
570 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 21 262 1.867e-07 1.524e-06
571 NEGATIVE REGULATION OF OSSIFICATION 11 69 1.923e-07 1.567e-06
572 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 33 573 1.963e-07 1.596e-06
573 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 19 218 1.972e-07 1.601e-06
574 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 16 156 2.015e-07 1.631e-06
575 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 16 156 2.015e-07 1.631e-06
576 RESPONSE TO TOXIC SUBSTANCE 20 241 2.092e-07 1.69e-06
577 CELL MATRIX ADHESION 14 119 2.146e-07 1.73e-06
578 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 6 14 2.186e-07 1.759e-06
579 ENDOCARDIAL CUSHION MORPHOGENESIS 7 22 2.261e-07 1.817e-06
580 SMAD PROTEIN SIGNAL TRANSDUCTION 10 56 2.303e-07 1.848e-06
581 POSITIVE REGULATION OF PROTEOLYSIS 25 363 2.4e-07 1.922e-06
582 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 8 32 2.437e-07 1.945e-06
583 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 32 2.437e-07 1.945e-06
584 REGULATION OF JNK CASCADE 16 159 2.621e-07 2.088e-06
585 CARDIAC MUSCLE TISSUE DEVELOPMENT 15 140 2.74e-07 2.18e-06
586 REGULATION OF CHEMOTAXIS 17 180 2.777e-07 2.205e-06
587 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 13 104 2.858e-07 2.265e-06
588 REGULATED EXOCYTOSIS 19 224 3.009e-07 2.381e-06
589 VESICLE MEDIATED TRANSPORT 54 1239 3.025e-07 2.39e-06
590 MYELOID CELL HOMEOSTASIS 12 88 3.138e-07 2.471e-06
591 ESTABLISHMENT OF CELL POLARITY 12 88 3.138e-07 2.471e-06
592 NEURON PROJECTION REGENERATION 8 33 3.157e-07 2.478e-06
593 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 8 33 3.157e-07 2.478e-06
594 TRABECULA FORMATION 7 23 3.192e-07 2.5e-06
595 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 75 1977 3.282e-07 2.566e-06
596 POSITIVE REGULATION OF RESPONSE TO WOUNDING 16 162 3.387e-07 2.644e-06
597 POSITIVE REGULATION OF STAT CASCADE 11 73 3.479e-07 2.707e-06
598 POSITIVE REGULATION OF JAK STAT CASCADE 11 73 3.479e-07 2.707e-06
599 EPITHELIAL CELL PROLIFERATION 12 89 3.559e-07 2.765e-06
600 CARDIAC MUSCLE CELL DIFFERENTIATION 11 74 4.01e-07 3.11e-06
601 COGNITION 20 251 4.022e-07 3.114e-06
602 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 8 34 4.054e-07 3.133e-06
603 ENDOCYTOSIS 30 509 4.414e-07 3.406e-06
604 CHONDROCYTE DIFFERENTIATION 10 60 4.524e-07 3.485e-06
605 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 11 75 4.611e-07 3.547e-06
606 MODULATION OF SYNAPTIC TRANSMISSION 22 301 4.696e-07 3.605e-06
607 ACTIVATION OF PROTEIN KINASE ACTIVITY 21 279 5.303e-07 4.065e-06
608 HEPATICOBILIARY SYSTEM DEVELOPMENT 14 128 5.314e-07 4.067e-06
609 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 13 110 5.526e-07 4.222e-06
610 MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION 6 16 5.623e-07 4.282e-06
611 MORPHOGENESIS OF AN ENDOTHELIUM 6 16 5.623e-07 4.282e-06
612 REGULATION OF REPRODUCTIVE PROCESS 14 129 5.849e-07 4.447e-06
613 APPENDAGE DEVELOPMENT 16 169 6.022e-07 4.564e-06
614 LIMB DEVELOPMENT 16 169 6.022e-07 4.564e-06
615 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 11 77 6.057e-07 4.576e-06
616 DIENCEPHALON DEVELOPMENT 11 77 6.057e-07 4.576e-06
617 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 13 111 6.141e-07 4.631e-06
618 EMBRYONIC HEART TUBE MORPHOGENESIS 10 62 6.215e-07 4.679e-06
619 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 20 258 6.226e-07 4.68e-06
620 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 21 282 6.319e-07 4.734e-06
621 MUSCLE SYSTEM PROCESS 21 282 6.319e-07 4.734e-06
622 REGULATION OF INNATE IMMUNE RESPONSE 24 357 6.472e-07 4.842e-06
623 RESPONSE TO BMP 12 94 6.513e-07 4.849e-06
624 CELLULAR RESPONSE TO BMP STIMULUS 12 94 6.513e-07 4.849e-06
625 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 8 36 6.511e-07 4.849e-06
626 RESPONSE TO AMINO ACID 13 112 6.816e-07 5.067e-06
627 RENAL TUBULE DEVELOPMENT 11 78 6.92e-07 5.136e-06
628 GLOMERULUS DEVELOPMENT 9 49 7.263e-07 5.381e-06
629 POSITIVE REGULATION OF T CELL PROLIFERATION 12 95 7.315e-07 5.403e-06
630 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 12 95 7.315e-07 5.403e-06
631 POSITIVE REGULATION OF CELL DIVISION 14 132 7.753e-07 5.717e-06
632 CORONARY VASCULATURE DEVELOPMENT 8 37 8.156e-07 5.995e-06
633 HINDLIMB MORPHOGENESIS 8 37 8.156e-07 5.995e-06
634 REGULATION OF EMBRYONIC DEVELOPMENT 13 114 8.369e-07 6.142e-06
635 REGULATION OF MUSCLE SYSTEM PROCESS 17 195 8.635e-07 6.327e-06
636 POSITIVE REGULATION OF DEFENSE RESPONSE 24 364 9.152e-07 6.696e-06
637 REGULATION OF GTPASE ACTIVITY 35 673 9.186e-07 6.71e-06
638 POSITIVE REGULATION OF ORGAN GROWTH 8 38 1.014e-06 7.374e-06
639 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 8 38 1.014e-06 7.374e-06
640 REGULATION OF GLUCONEOGENESIS 8 38 1.014e-06 7.374e-06
641 CELL GROWTH 14 135 1.02e-06 7.401e-06
642 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 12 98 1.027e-06 7.444e-06
643 REGULATION OF PROTEIN CATABOLIC PROCESS 25 393 1.045e-06 7.566e-06
644 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 7 27 1.075e-06 7.756e-06
645 POSITIVE REGULATION OF HEART GROWTH 7 27 1.075e-06 7.756e-06
646 REGULATION OF PROTEIN STABILITY 18 221 1.115e-06 8.033e-06
647 SPECIFICATION OF SYMMETRY 13 117 1.129e-06 8.121e-06
648 POSITIVE REGULATION OF CATABOLIC PROCESS 25 395 1.147e-06 8.233e-06
649 DIVALENT INORGANIC CATION HOMEOSTASIS 23 343 1.159e-06 8.308e-06
650 ACTIN FILAMENT BASED PROCESS 27 450 1.198e-06 8.573e-06
651 NEGATIVE REGULATION OF SECRETION 17 200 1.229e-06 8.784e-06
652 CELLULAR RESPONSE TO NUTRIENT 8 39 1.253e-06 8.926e-06
653 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 8 39 1.253e-06 8.926e-06
654 NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 6 18 1.258e-06 8.948e-06
655 REGULATION OF ION HOMEOSTASIS 17 201 1.317e-06 9.356e-06
656 NEGATIVE REGULATION OF CELL CELL ADHESION 14 138 1.331e-06 9.423e-06
657 MAINTENANCE OF LOCATION 14 138 1.331e-06 9.423e-06
658 TISSUE MIGRATION 11 84 1.476e-06 1.044e-05
659 CYTOKINE PRODUCTION 13 120 1.509e-06 1.066e-05
660 MAMMARY GLAND MORPHOGENESIS 8 40 1.537e-06 1.08e-05
661 FORELIMB MORPHOGENESIS 8 40 1.537e-06 1.08e-05
662 ENDOCRINE PANCREAS DEVELOPMENT 8 40 1.537e-06 1.08e-05
663 NEURON PROJECTION GUIDANCE 17 205 1.729e-06 1.213e-05
664 CELL PART MORPHOGENESIS 33 633 1.804e-06 1.256e-05
665 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 6 19 1.806e-06 1.256e-05
666 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 6 19 1.806e-06 1.256e-05
667 ATRIOVENTRICULAR VALVE DEVELOPMENT 6 19 1.806e-06 1.256e-05
668 ASTROCYTE DEVELOPMENT 6 19 1.806e-06 1.256e-05
669 ESTROUS CYCLE 6 19 1.806e-06 1.256e-05
670 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 7 29 1.822e-06 1.262e-05
671 REGULATION OF HEART MORPHOGENESIS 7 29 1.822e-06 1.262e-05
672 MUSCLE ADAPTATION 7 29 1.822e-06 1.262e-05
673 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 8 41 1.875e-06 1.296e-05
674 ION HOMEOSTASIS 31 576 1.945e-06 1.343e-05
675 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 9 55 2.01e-06 1.384e-05
676 REGULATION OF KIDNEY DEVELOPMENT 9 55 2.01e-06 1.384e-05
677 HORMONE METABOLIC PROCESS 15 164 2.091e-06 1.437e-05
678 REGULATION OF JAK STAT CASCADE 14 144 2.218e-06 1.52e-05
679 REGULATION OF STAT CASCADE 14 144 2.218e-06 1.52e-05
680 ENDODERM DEVELOPMENT 10 71 2.255e-06 1.543e-05
681 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 42 2.274e-06 1.554e-05
682 BROWN FAT CELL DIFFERENTIATION 7 30 2.334e-06 1.592e-05
683 CELLULAR RESPONSE TO INTERLEUKIN 1 11 88 2.358e-06 1.602e-05
684 OVULATION CYCLE PROCESS 11 88 2.358e-06 1.602e-05
685 REGULATION OF STEM CELL PROLIFERATION 11 88 2.358e-06 1.602e-05
686 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 6 20 2.534e-06 1.719e-05
687 POSITIVE REGULATION OF PROTEIN SECRETION 17 211 2.567e-06 1.739e-05
688 B CELL DIFFERENTIATION 11 89 2.641e-06 1.786e-05
689 ENDOTHELIAL CELL MIGRATION 9 57 2.741e-06 1.847e-05
690 MORPHOGENESIS OF AN EPITHELIAL SHEET 8 43 2.743e-06 1.847e-05
691 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 8 43 2.743e-06 1.847e-05
692 RESPONSE TO PHENYLPROPANOID 5 12 2.83e-06 1.897e-05
693 REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 5 12 2.83e-06 1.897e-05
694 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 5 12 2.83e-06 1.897e-05
695 REGULATION OF OXIDOREDUCTASE ACTIVITY 11 90 2.952e-06 1.977e-05
696 REGULATION OF APOPTOTIC SIGNALING PATHWAY 23 363 3.027e-06 2.023e-05
697 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 16 191 3.054e-06 2.039e-05
698 INNATE IMMUNE RESPONSE 32 619 3.097e-06 2.065e-05
699 NEGATIVE REGULATION OF HEMOPOIESIS 13 128 3.134e-06 2.086e-05
700 NEURAL TUBE DEVELOPMENT 14 149 3.326e-06 2.207e-05
701 REGULATION OF LEUKOCYTE MIGRATION 14 149 3.326e-06 2.207e-05
702 SENSORY ORGAN MORPHOGENESIS 18 239 3.413e-06 2.26e-05
703 REGULATION OF ION TRANSPORT 31 592 3.415e-06 2.26e-05
704 CELLULAR RESPONSE TO OSMOTIC STRESS 6 21 3.485e-06 2.303e-05
705 PROXIMAL DISTAL PATTERN FORMATION 7 32 3.721e-06 2.449e-05
706 NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 7 32 3.721e-06 2.449e-05
707 BLOOD VESSEL REMODELING 7 32 3.721e-06 2.449e-05
708 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 10 75 3.756e-06 2.468e-05
709 CELL MATURATION 13 131 4.061e-06 2.66e-05
710 REGULATION OF CELLULAR KETONE METABOLIC PROCESS 15 173 4.064e-06 2.66e-05
711 REGULATION OF CELL SUBSTRATE ADHESION 15 173 4.064e-06 2.66e-05
712 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 14 152 4.206e-06 2.748e-05
713 REGULATION OF MONOOXYGENASE ACTIVITY 9 60 4.26e-06 2.78e-05
714 REGULATION OF LYMPHOCYTE DIFFERENTIATION 13 132 4.42e-06 2.88e-05
715 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 5 13 4.519e-06 2.929e-05
716 RESPONSE TO HEPATOCYTE GROWTH FACTOR 5 13 4.519e-06 2.929e-05
717 RESPONSE TO PARATHYROID HORMONE 5 13 4.519e-06 2.929e-05
718 MESENCHYMAL CELL PROLIFERATION 5 13 4.519e-06 2.929e-05
719 RESPONSE TO DEXAMETHASONE 7 33 4.637e-06 3.001e-05
720 NEGATIVE REGULATION OF DNA BINDING 8 46 4.671e-06 3.014e-05
721 REGULATION OF CHONDROCYTE DIFFERENTIATION 8 46 4.671e-06 3.014e-05
722 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 15 175 4.682e-06 3.016e-05
723 INTERSPECIES INTERACTION BETWEEN ORGANISMS 33 662 4.692e-06 3.016e-05
724 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 33 662 4.692e-06 3.016e-05
725 PROTEIN LOCALIZATION TO CELL SURFACE 6 22 4.706e-06 3.016e-05
726 AORTA MORPHOGENESIS 6 22 4.706e-06 3.016e-05
727 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 9 61 4.905e-06 3.135e-05
728 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 14 154 4.902e-06 3.135e-05
729 MULTICELLULAR ORGANISMAL HOMEOSTASIS 19 272 5.509e-06 3.516e-05
730 REGULATION OF TISSUE REMODELING 9 62 5.632e-06 3.59e-05
731 RESPONSE TO CALCIUM ION 12 115 5.653e-06 3.598e-05
732 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 14 156 5.699e-06 3.622e-05
733 REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 34 5.735e-06 3.635e-05
734 PROTEIN KINASE B SIGNALING 7 34 5.735e-06 3.635e-05
735 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 11 97 6.188e-06 3.917e-05
736 STRIATED MUSCLE ADAPTATION 6 23 6.255e-06 3.954e-05
737 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 9 63 6.45e-06 4.072e-05
738 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 8 48 6.51e-06 4.083e-05
739 REGULATION OF MYOBLAST DIFFERENTIATION 8 48 6.51e-06 4.083e-05
740 REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 8 48 6.51e-06 4.083e-05
741 POSITIVE REGULATION OF WOUND HEALING 8 48 6.51e-06 4.083e-05
742 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 8 48 6.51e-06 4.083e-05
743 NEGATIVE REGULATION OF CELL ACTIVATION 14 158 6.608e-06 4.138e-05
744 RESPONSE TO ALKALOID 13 137 6.67e-06 4.166e-05
745 ACTIVATION OF MAPK ACTIVITY 13 137 6.67e-06 4.166e-05
746 NEGATIVE REGULATION OF CATABOLIC PROCESS 16 203 6.692e-06 4.174e-05
747 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 10 80 6.795e-06 4.232e-05
748 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 5 14 6.908e-06 4.263e-05
749 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 5 14 6.908e-06 4.263e-05
750 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 5 14 6.908e-06 4.263e-05
751 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 5 14 6.908e-06 4.263e-05
752 POSITIVE REGULATION OF FATTY ACID OXIDATION 5 14 6.908e-06 4.263e-05
753 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 14 6.908e-06 4.263e-05
754 RESPONSE TO LAMINAR FLUID SHEAR STRESS 5 14 6.908e-06 4.263e-05
755 TELENCEPHALON DEVELOPMENT 17 228 7.278e-06 4.485e-05
756 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 12 118 7.39e-06 4.548e-05
757 MYELOID LEUKOCYTE MIGRATION 11 99 7.552e-06 4.642e-05
758 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 8 49 7.639e-06 4.659e-05
759 REGULATION OF FIBROBLAST PROLIFERATION 10 81 7.608e-06 4.659e-05
760 CELLULAR RESPONSE TO CALCIUM ION 8 49 7.639e-06 4.659e-05
761 REGULATION OF STEROID BIOSYNTHETIC PROCESS 8 49 7.639e-06 4.659e-05
762 CARDIAC SEPTUM MORPHOGENESIS 8 49 7.639e-06 4.659e-05
763 CARDIAC CELL DEVELOPMENT 8 49 7.639e-06 4.659e-05
764 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 6 24 8.192e-06 4.963e-05
765 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 24 8.192e-06 4.963e-05
766 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 6 24 8.192e-06 4.963e-05
767 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 6 24 8.192e-06 4.963e-05
768 ERYTHROCYTE DEVELOPMENT 6 24 8.192e-06 4.963e-05
769 REGULATION OF CHEMOKINE PRODUCTION 9 65 8.395e-06 5.079e-05
770 RECEPTOR METABOLIC PROCESS 10 82 8.504e-06 5.132e-05
771 KIDNEY MORPHOGENESIS 10 82 8.504e-06 5.132e-05
772 POSITIVE CHEMOTAXIS 7 36 8.581e-06 5.172e-05
773 POSITIVE REGULATION OF CHEMOTAXIS 12 120 8.793e-06 5.293e-05
774 REGULATION OF PEPTIDE TRANSPORT 18 256 8.871e-06 5.333e-05
775 VASCULAR PROCESS IN CIRCULATORY SYSTEM 14 163 9.47e-06 5.685e-05
776 REGULATION OF B CELL ACTIVATION 12 121 9.579e-06 5.743e-05
777 RESPONSE TO TUMOR NECROSIS FACTOR 17 233 9.692e-06 5.804e-05
778 POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 5 15 1.018e-05 6.082e-05
779 VENOUS BLOOD VESSEL DEVELOPMENT 5 15 1.018e-05 6.082e-05
780 EXOCYTOSIS 20 310 1.025e-05 6.113e-05
781 LIPID MODIFICATION 16 210 1.028e-05 6.124e-05
782 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 8 51 1.04e-05 6.178e-05
783 NEURAL CREST CELL MIGRATION 8 51 1.04e-05 6.178e-05
784 NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 10 84 1.057e-05 6.275e-05
785 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 9 67 1.082e-05 6.413e-05
786 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 13 144 1.15e-05 6.806e-05
787 CARDIAC SEPTUM DEVELOPMENT 10 85 1.176e-05 6.953e-05
788 REGULATION OF HORMONE SECRETION 18 262 1.217e-05 7.177e-05
789 REGULATION OF INTERLEUKIN 6 PRODUCTION 11 104 1.216e-05 7.177e-05
790 BONE MINERALIZATION 7 38 1.251e-05 7.35e-05
791 REGULATION OF STEROL TRANSPORT 7 38 1.251e-05 7.35e-05
792 REGULATION OF CHOLESTEROL TRANSPORT 7 38 1.251e-05 7.35e-05
793 POSITIVE REGULATION OF B CELL ACTIVATION 10 86 1.306e-05 7.664e-05
794 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 23 397 1.311e-05 7.681e-05
795 HEART TRABECULA MORPHOGENESIS 6 26 1.352e-05 7.904e-05
796 REGULATION OF HORMONE METABOLIC PROCESS 6 26 1.352e-05 7.904e-05
797 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 8 53 1.395e-05 8.134e-05
798 NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 8 53 1.395e-05 8.134e-05
799 EXTRACELLULAR MATRIX ASSEMBLY 5 16 1.456e-05 8.435e-05
800 REGULATION OF FATTY ACID METABOLIC PROCESS 10 87 1.449e-05 8.435e-05
801 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 5 16 1.456e-05 8.435e-05
802 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 5 16 1.456e-05 8.435e-05
803 ATRIOVENTRICULAR VALVE MORPHOGENESIS 5 16 1.456e-05 8.435e-05
804 SPINAL CORD DEVELOPMENT 11 106 1.46e-05 8.44e-05
805 CARDIAC VENTRICLE DEVELOPMENT 11 106 1.46e-05 8.44e-05
806 RESPONSE TO TEMPERATURE STIMULUS 13 148 1.546e-05 8.911e-05
807 RESPONSE TO TRANSITION METAL NANOPARTICLE 13 148 1.546e-05 8.911e-05
808 REGULATION OF T CELL DIFFERENTIATION 11 107 1.597e-05 9.197e-05
809 TISSUE HOMEOSTASIS 14 171 1.635e-05 9.405e-05
810 REGULATION OF PROTEIN COMPLEX ASSEMBLY 22 375 1.664e-05 9.557e-05
811 CELL FATE SPECIFICATION 9 71 1.75e-05 0.0001004
812 REGULATION OF MYOTUBE DIFFERENTIATION 8 55 1.847e-05 0.0001059
813 AXIS SPECIFICATION 10 90 1.958e-05 0.0001121
814 NEGATIVE REGULATION OF LIPID STORAGE 5 17 2.027e-05 0.0001157
815 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 5 17 2.027e-05 0.0001157
816 REGULATION OF CHROMATIN ORGANIZATION 13 152 2.056e-05 0.0001173
817 REGULATION OF LIPID STORAGE 7 41 2.111e-05 0.0001195
818 AORTA DEVELOPMENT 7 41 2.111e-05 0.0001195
819 REGULATION OF B CELL MEDIATED IMMUNITY 7 41 2.111e-05 0.0001195
820 CELL SUBSTRATE JUNCTION ASSEMBLY 7 41 2.111e-05 0.0001195
821 PROSTATE GLAND DEVELOPMENT 7 41 2.111e-05 0.0001195
822 LUNG ALVEOLUS DEVELOPMENT 7 41 2.111e-05 0.0001195
823 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 6 28 2.135e-05 0.0001206
824 MUSCLE HYPERTROPHY 6 28 2.135e-05 0.0001206
825 PROTEIN STABILIZATION 12 131 2.15e-05 0.0001213
826 DORSAL VENTRAL PATTERN FORMATION 10 91 2.16e-05 0.0001214
827 ENSHEATHMENT OF NEURONS 10 91 2.16e-05 0.0001214
828 AXON ENSHEATHMENT 10 91 2.16e-05 0.0001214
829 ERYTHROCYTE HOMEOSTASIS 9 73 2.198e-05 0.0001232
830 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 9 73 2.198e-05 0.0001232
831 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 12 132 2.321e-05 0.0001299
832 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 15 200 2.331e-05 0.0001304
833 REGULATION OF MULTI ORGANISM PROCESS 25 470 2.36e-05 0.0001318
834 CELLULAR LIPID METABOLIC PROCESS 39 913 2.364e-05 0.0001319
835 NEGATIVE REGULATION OF HORMONE SECRETION 9 74 2.456e-05 0.0001366
836 REGULATION OF STEROID METABOLIC PROCESS 9 74 2.456e-05 0.0001366
837 CELL CELL JUNCTION ASSEMBLY 9 74 2.456e-05 0.0001366
838 EAR MORPHOGENESIS 11 112 2.463e-05 0.0001367
839 PITUITARY GLAND DEVELOPMENT 7 42 2.487e-05 0.000138
840 EMBRYONIC HINDLIMB MORPHOGENESIS 6 29 2.645e-05 0.0001465
841 LIPID METABOLIC PROCESS 46 1158 2.672e-05 0.0001478
842 PROTEIN LOCALIZATION TO NUCLEUS 13 156 2.71e-05 0.0001497
843 OVULATION 5 18 2.758e-05 0.0001512
844 REGULATION OF INTERLEUKIN 1 PRODUCTION 8 58 2.752e-05 0.0001512
845 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 5 18 2.758e-05 0.0001512
846 RESPONSE TO CAFFEINE 5 18 2.758e-05 0.0001512
847 REGULATION OF HORMONE BIOSYNTHETIC PROCESS 5 18 2.758e-05 0.0001512
848 BIOMINERAL TISSUE DEVELOPMENT 9 75 2.74e-05 0.0001512
849 POSITIVE REGULATION OF CELL CYCLE 20 332 2.759e-05 0.0001512
850 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 15 203 2.775e-05 0.0001519
851 HEXOSE METABOLIC PROCESS 13 157 2.899e-05 0.0001585
852 RESPONSE TO COLD 7 43 2.918e-05 0.0001588
853 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 7 43 2.918e-05 0.0001588
854 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 43 2.918e-05 0.0001588
855 CELL FATE DETERMINATION 7 43 2.918e-05 0.0001588
856 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 15 204 2.939e-05 0.0001598
857 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 12 136 3.127e-05 0.0001698
858 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 6 30 3.248e-05 0.0001761
859 CIRCADIAN RHYTHM 12 137 3.364e-05 0.000182
860 HINDBRAIN DEVELOPMENT 12 137 3.364e-05 0.000182
861 MYELOID CELL DEVELOPMENT 7 44 3.408e-05 0.0001837
862 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 7 44 3.408e-05 0.0001837
863 ENDOCRINE PROCESS 7 44 3.408e-05 0.0001837
864 MAINTENANCE OF LOCATION IN CELL 10 96 3.453e-05 0.0001857
865 POSITIVE REGULATION OF CYTOKINE SECRETION 10 96 3.453e-05 0.0001857
866 SECOND MESSENGER MEDIATED SIGNALING 13 160 3.537e-05 0.0001901
867 RESPONSE TO MUSCLE STRETCH 5 19 3.678e-05 0.0001958
868 CELLULAR RESPONSE TO FLUID SHEAR STRESS 5 19 3.678e-05 0.0001958
869 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 5 19 3.678e-05 0.0001958
870 NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 5 19 3.678e-05 0.0001958
871 GAS TRANSPORT 5 19 3.678e-05 0.0001958
872 NEGATIVE REGULATION OF ATP METABOLIC PROCESS 5 19 3.678e-05 0.0001958
873 ENTEROENDOCRINE CELL DIFFERENTIATION 5 19 3.678e-05 0.0001958
874 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 19 3.678e-05 0.0001958
875 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 14 184 3.707e-05 0.0001971
876 ANATOMICAL STRUCTURE HOMEOSTASIS 18 285 3.741e-05 0.0001987
877 LYMPHOCYTE COSTIMULATION 9 78 3.764e-05 0.0001997
878 REGULATION OF CALCIUM ION TRANSPORT 15 209 3.892e-05 0.000206
879 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 15 209 3.892e-05 0.000206
880 CARDIAC ATRIUM DEVELOPMENT 6 31 3.956e-05 0.0002087
881 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 6 31 3.956e-05 0.0002087
882 REGULATION OF PLATELET ACTIVATION 6 31 3.956e-05 0.0002087
883 ENDOTHELIAL CELL DEVELOPMENT 7 45 3.963e-05 0.0002088
884 MEMBRANE DEPOLARIZATION 8 61 4.002e-05 0.0002102
885 EMBRYONIC DIGIT MORPHOGENESIS 8 61 4.002e-05 0.0002102
886 REGULATION OF INTERLEUKIN 8 PRODUCTION 8 61 4.002e-05 0.0002102
887 MESODERM DEVELOPMENT 11 118 4.012e-05 0.0002105
888 MEMORY 10 98 4.13e-05 0.0002157
889 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 10 98 4.13e-05 0.0002157
890 MYELOID LEUKOCYTE ACTIVATION 10 98 4.13e-05 0.0002157
891 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 10 98 4.13e-05 0.0002157
892 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 9 79 4.17e-05 0.000217
893 NEGATIVE REGULATION OF PROTEIN BINDING 9 79 4.17e-05 0.000217
894 BONE MORPHOGENESIS 9 79 4.17e-05 0.000217
895 ADAPTIVE IMMUNE RESPONSE 18 288 4.289e-05 0.000223
896 REGULATION OF NUCLEAR DIVISION 13 163 4.296e-05 0.0002231
897 SKIN DEVELOPMENT 15 211 4.344e-05 0.0002253
898 FOREBRAIN CELL MIGRATION 8 62 4.512e-05 0.0002338
899 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 7 46 4.59e-05 0.0002376
900 REGULATION OF ORGAN FORMATION 6 32 4.783e-05 0.0002467
901 EMBRYONIC FORELIMB MORPHOGENESIS 6 32 4.783e-05 0.0002467
902 METANEPHRIC NEPHRON DEVELOPMENT 6 32 4.783e-05 0.0002467
903 METENCEPHALON DEVELOPMENT 10 100 4.918e-05 0.0002531
904 LIMBIC SYSTEM DEVELOPMENT 10 100 4.918e-05 0.0002531
905 REGULATION OF OSTEOCLAST DIFFERENTIATION 8 63 5.074e-05 0.0002606
906 REGULATION OF MUSCLE ADAPTATION 8 63 5.074e-05 0.0002606
907 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 9 81 5.094e-05 0.0002613
908 RAS PROTEIN SIGNAL TRANSDUCTION 12 143 5.133e-05 0.000263
909 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 47 5.297e-05 0.0002708
910 REGULATION OF IMMUNOGLOBULIN PRODUCTION 7 47 5.297e-05 0.0002708
911 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 10 101 5.357e-05 0.0002736
912 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 12 144 5.495e-05 0.0002804
913 INTEGRIN MEDIATED SIGNALING PATHWAY 9 82 5.617e-05 0.0002863
914 NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 4 11 5.681e-05 0.0002882
915 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 15 216 5.68e-05 0.0002882
916 NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS 4 11 5.681e-05 0.0002882
917 POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 11 5.681e-05 0.0002882
918 REGULATION OF PHOSPHOLIPASE ACTIVITY 8 64 5.694e-05 0.0002886
919 DENDRITIC CELL DIFFERENTIATION 6 33 5.743e-05 0.0002898
920 POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 6 33 5.743e-05 0.0002898
921 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 6 33 5.743e-05 0.0002898
922 RESPONSE TO VITAMIN D 6 33 5.743e-05 0.0002898
923 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 10 102 5.83e-05 0.0002939
924 REGULATION OF BLOOD CIRCULATION 18 295 5.855e-05 0.0002949
925 RESPONSE TO IONIZING RADIATION 12 145 5.879e-05 0.0002956
926 REGULATION OF ADAPTIVE IMMUNE RESPONSE 11 123 5.883e-05 0.0002956
927 RESPONSE TO AXON INJURY 7 48 6.09e-05 0.0003057
928 REGULATION OF LIPASE ACTIVITY 9 83 6.184e-05 0.0003101
929 REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS 5 21 6.217e-05 0.0003107
930 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 5 21 6.217e-05 0.0003107
931 CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 5 21 6.217e-05 0.0003107
932 REGULATION OF METAL ION TRANSPORT 19 325 6.524e-05 0.0003257
933 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 16 245 6.761e-05 0.0003372
934 ORGAN FORMATION 6 34 6.851e-05 0.0003409
935 PROTEIN DESTABILIZATION 6 34 6.851e-05 0.0003409
936 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 9 85 7.466e-05 0.0003711
937 NEGATIVE REGULATION OF PROTEOLYSIS 19 329 7.674e-05 0.0003811
938 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 14 197 7.794e-05 0.0003866
939 NEGATIVE REGULATION OF ION TRANSPORT 11 127 7.878e-05 0.0003904
940 REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 22 7.907e-05 0.0003906
941 EMBRYONIC PLACENTA MORPHOGENESIS 5 22 7.907e-05 0.0003906
942 HISTONE H3 DEACETYLATION 5 22 7.907e-05 0.0003906
943 FACE DEVELOPMENT 7 50 7.969e-05 0.0003915
944 STAT CASCADE 7 50 7.969e-05 0.0003915
945 RECEPTOR INTERNALIZATION 7 50 7.969e-05 0.0003915
946 JAK STAT CASCADE 7 50 7.969e-05 0.0003915
947 ENDODERM FORMATION 7 50 7.969e-05 0.0003915
948 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 35 8.122e-05 0.0003974
949 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE 6 35 8.122e-05 0.0003974
950 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 6 35 8.122e-05 0.0003974
951 RESPONSE TO MONOAMINE 6 35 8.122e-05 0.0003974
952 POSITIVE REGULATION OF DNA REPLICATION 9 86 8.186e-05 0.0004001
953 NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 4 12 8.38e-05 0.0004078
954 CARTILAGE MORPHOGENESIS 4 12 8.38e-05 0.0004078
955 HEMATOPOIETIC STEM CELL DIFFERENTIATION 4 12 8.38e-05 0.0004078
956 NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 4 12 8.38e-05 0.0004078
957 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 8 68 8.837e-05 0.0004292
958 ORGAN GROWTH 8 68 8.837e-05 0.0004292
959 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 9 87 8.963e-05 0.0004322
960 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 9 87 8.963e-05 0.0004322
961 VIRAL ENTRY INTO HOST CELL 9 87 8.963e-05 0.0004322
962 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 9 87 8.963e-05 0.0004322
963 MOVEMENT IN HOST ENVIRONMENT 9 87 8.963e-05 0.0004322
964 ENTRY INTO HOST 9 87 8.963e-05 0.0004322
965 ENTRY INTO HOST CELL 9 87 8.963e-05 0.0004322
966 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 51 9.071e-05 0.000436
967 CELLULAR RESPONSE TO FATTY ACID 7 51 9.071e-05 0.000436
968 REGULATION OF INTERLEUKIN 12 PRODUCTION 7 51 9.071e-05 0.000436
969 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 17 278 9.101e-05 0.0004365
970 REGULATION OF CHROMOSOME ORGANIZATION 17 278 9.101e-05 0.0004365
971 NEGATIVE REGULATION OF PROTEIN SECRETION 10 108 9.478e-05 0.0004542
972 REGULATION OF ERYTHROCYTE DIFFERENTIATION 6 36 9.575e-05 0.0004579
973 T CELL SELECTION 6 36 9.575e-05 0.0004579
974 CYTOSKELETON ORGANIZATION 35 838 9.765e-05 0.0004665
975 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 9 88 9.801e-05 0.0004678
976 EPIDERMIS DEVELOPMENT 16 253 9.863e-05 0.0004702
977 RESPONSE TO INCREASED OXYGEN LEVELS 5 23 9.93e-05 0.0004719
978 REGULATION OF METANEPHROS DEVELOPMENT 5 23 9.93e-05 0.0004719
979 RESPONSE TO HYPEROXIA 5 23 9.93e-05 0.0004719
980 TISSUE REGENERATION 7 52 0.0001029 0.0004888
981 CELLULAR COMPONENT DISASSEMBLY 25 515 0.0001032 0.0004894
982 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 9 89 0.000107 0.0005072
983 NEURON MIGRATION 10 110 0.0001106 0.0005235
984 MAINTENANCE OF CELL NUMBER 11 132 0.0001116 0.0005279
985 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 12 155 0.0001118 0.0005283
986 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 6 37 0.0001123 0.0005293
987 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 37 0.0001123 0.0005293
988 HEMOSTASIS 18 311 0.0001147 0.0005401
989 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 7 53 0.0001165 0.0005475
990 MESONEPHRIC TUBULE MORPHOGENESIS 7 53 0.0001165 0.0005475
991 REGULATION OF CELL MATRIX ADHESION 9 90 0.0001168 0.0005482
992 TYPE B PANCREATIC CELL DEVELOPMENT 4 13 0.000119 0.0005533
993 LIPOPROTEIN TRANSPORT 4 13 0.000119 0.0005533
994 LEFT RIGHT AXIS SPECIFICATION 4 13 0.000119 0.0005533
995 CARDIOBLAST DIFFERENTIATION 4 13 0.000119 0.0005533
996 NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 4 13 0.000119 0.0005533
997 LIPOPROTEIN LOCALIZATION 4 13 0.000119 0.0005533
998 NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 4 13 0.000119 0.0005533
999 LYMPH VESSEL MORPHOGENESIS 4 13 0.000119 0.0005533
1000 POSITIVE REGULATION OF GLUCONEOGENESIS 4 13 0.000119 0.0005533
1001 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 13 0.000119 0.0005533
1002 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 11 133 0.0001194 0.0005541
1003 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 11 133 0.0001194 0.0005541
1004 ADHERENS JUNCTION ORGANIZATION 8 71 0.0001204 0.000558
1005 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 5 24 0.0001233 0.0005673
1006 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 5 24 0.0001233 0.0005673
1007 AXON REGENERATION 5 24 0.0001233 0.0005673
1008 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 24 0.0001233 0.0005673
1009 REGULATION OF ODONTOGENESIS 5 24 0.0001233 0.0005673
1010 REGULATION OF ISOTYPE SWITCHING 5 24 0.0001233 0.0005673
1011 POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 5 24 0.0001233 0.0005673
1012 INTERACTION WITH HOST 11 134 0.0001277 0.0005872
1013 RESPONSE TO TESTOSTERONE 6 38 0.000131 0.000601
1014 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 6 38 0.000131 0.000601
1015 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 7 54 0.0001314 0.000602
1016 ALPHA BETA T CELL ACTIVATION 7 54 0.0001314 0.000602
1017 HORMONE MEDIATED SIGNALING PATHWAY 12 158 0.0001342 0.0006139
1018 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 11 135 0.0001365 0.0006237
1019 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 10 113 0.0001385 0.0006323
1020 REGULATION OF CELL CYCLE PROCESS 26 558 0.0001453 0.0006627
1021 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 8 73 0.0001467 0.0006684
1022 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 10 114 0.000149 0.0006783
1023 POSITIVE REGULATION OF BLOOD CIRCULATION 9 93 0.0001505 0.0006843
1024 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 5 25 0.0001514 0.0006881
1025 LONG TERM SYNAPTIC POTENTIATION 6 39 0.0001521 0.000689
1026 NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION 6 39 0.0001521 0.000689
1027 EMBRYO IMPLANTATION 6 39 0.0001521 0.000689
1028 POSITIVE REGULATION OF ION TRANSPORT 15 236 0.000153 0.0006925
1029 REGULATION OF DNA REPLICATION 12 161 0.0001602 0.0007245
1030 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 8 74 0.0001615 0.0007294
1031 REGULATION OF MITOTIC CELL CYCLE 23 468 0.0001623 0.0007326
1032 POSITIVE REGULATION OF CHOLESTEROL EFFLUX 4 14 0.0001639 0.0007339
1033 POSITIVE REGULATION OF URINE VOLUME 4 14 0.0001639 0.0007339
1034 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 9 94 0.0001633 0.0007339
1035 HEART TRABECULA FORMATION 4 14 0.0001639 0.0007339
1036 REGULATION OF PROTEIN KINASE C SIGNALING 4 14 0.0001639 0.0007339
1037 ANGIOGENESIS INVOLVED IN WOUND HEALING 4 14 0.0001639 0.0007339
1038 MIDGUT DEVELOPMENT 4 14 0.0001639 0.0007339
1039 POST EMBRYONIC ORGAN DEVELOPMENT 4 14 0.0001639 0.0007339
1040 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 6 40 0.0001758 0.0007848
1041 DEVELOPMENTAL PIGMENTATION 6 40 0.0001758 0.0007848
1042 HINDBRAIN MORPHOGENESIS 6 40 0.0001758 0.0007848
1043 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 11 139 0.0001768 0.0007878
1044 REGULATION OF CELL SHAPE 11 139 0.0001768 0.0007878
1045 SENSORY PERCEPTION OF PAIN 8 75 0.0001775 0.0007895
1046 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 8 75 0.0001775 0.0007895
1047 DEVELOPMENTAL PROGRAMMED CELL DEATH 5 26 0.0001843 0.0008151
1048 POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 5 26 0.0001843 0.0008151
1049 REGULATION OF NECROTIC CELL DEATH 5 26 0.0001843 0.0008151
1050 POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 5 26 0.0001843 0.0008151
1051 REGULATION OF P38MAPK CASCADE 5 26 0.0001843 0.0008151
1052 CELLULAR RESPONSE TO VITAMIN 5 26 0.0001843 0.0008151
1053 LEUKOCYTE CHEMOTAXIS 10 117 0.0001847 0.000816
1054 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 7 57 0.0001859 0.0008206
1055 REGULATION OF SYNAPTIC PLASTICITY 11 140 0.0001883 0.0008303
1056 NEGATIVE REGULATION OF WOUND HEALING 7 58 0.0002076 0.0009148
1057 GLUCOSE METABOLIC PROCESS 10 119 0.0002122 0.0009343
1058 PLATELET ACTIVATION 11 142 0.0002132 0.0009368
1059 DETOXIFICATION 8 77 0.0002134 0.0009368
1060 DEVELOPMENTAL CELL GROWTH 8 77 0.0002134 0.0009368
1061 RESPONSE TO MURAMYL DIPEPTIDE 4 15 0.0002198 0.0009593
1062 INTERLEUKIN 1 PRODUCTION 4 15 0.0002198 0.0009593
1063 NEGATIVE REGULATION OF HISTONE ACETYLATION 4 15 0.0002198 0.0009593
1064 ENDOCARDIAL CUSHION FORMATION 4 15 0.0002198 0.0009593
1065 OXYGEN TRANSPORT 4 15 0.0002198 0.0009593
1066 NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 4 15 0.0002198 0.0009593
1067 NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION 5 27 0.0002223 0.0009657
1068 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 27 0.0002223 0.0009657
1069 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 5 27 0.0002223 0.0009657
1070 AXIS ELONGATION 5 27 0.0002223 0.0009657
1071 POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 5 27 0.0002223 0.0009657
1072 REGULATION OF DENDRITE DEVELOPMENT 10 120 0.0002273 0.0009865
1073 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 6 42 0.0002318 0.001002
1074 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 6 42 0.0002318 0.001002
1075 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 42 0.0002318 0.001002
1076 POSITIVE REGULATION OF GLUCOSE TRANSPORT 6 42 0.0002318 0.001002
1077 EPITHELIAL CELL MORPHOGENESIS 6 42 0.0002318 0.001002
1078 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 15 246 0.0002403 0.001037
1079 LIPID PHOSPHORYLATION 9 99 0.0002424 0.001045
1080 REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 16 274 0.0002459 0.001059
1081 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 23 482 0.0002482 0.001068
1082 POSITIVE REGULATION OF CELL CYCLE PROCESS 15 247 0.000251 0.001079
1083 REGULATION OF GLUCOSE IMPORT 7 60 0.0002572 0.001103
1084 OLIGODENDROCYTE DIFFERENTIATION 7 60 0.0002572 0.001103
1085 LEUKOCYTE HOMEOSTASIS 7 60 0.0002572 0.001103
1086 MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM 9 100 0.0002615 0.00112
1087 DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 6 43 0.0002647 0.001133
1088 PLACENTA BLOOD VESSEL DEVELOPMENT 5 28 0.000266 0.001135
1089 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 5 28 0.000266 0.001135
1090 REGULATION OF FATTY ACID OXIDATION 5 28 0.000266 0.001135
1091 REGULATION OF AUTOPHAGY 15 249 0.0002737 0.001167
1092 ADULT LOCOMOTORY BEHAVIOR 8 80 0.0002783 0.001186
1093 NOTCH RECEPTOR PROCESSING 4 16 0.0002882 0.001215
1094 REGULATION OF MUSCLE CONTRACTION 11 147 0.0002881 0.001215
1095 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 4 16 0.0002882 0.001215
1096 POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 4 16 0.0002882 0.001215
1097 ORGAN INDUCTION 4 16 0.0002882 0.001215
1098 NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT 4 16 0.0002882 0.001215
1099 NEGATIVE REGULATION OF CHEMOKINE PRODUCTION 4 16 0.0002882 0.001215
1100 RESPONSE TO EPINEPHRINE 4 16 0.0002882 0.001215
1101 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 4 16 0.0002882 0.001215
1102 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 0.0002882 0.001215
1103 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 16 0.0002882 0.001215
1104 MONOCYTE DIFFERENTIATION 4 16 0.0002882 0.001215
1105 LABYRINTHINE LAYER DEVELOPMENT 6 44 0.0003011 0.001265
1106 BODY MORPHOGENESIS 6 44 0.0003011 0.001265
1107 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 6 44 0.0003011 0.001265
1108 NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 6 44 0.0003011 0.001265
1109 REGULATION OF JUN KINASE ACTIVITY 8 81 0.0003032 0.001272
1110 RENAL SYSTEM PROCESS 9 102 0.0003035 0.001272
1111 REGULATION OF TRANSPORTER ACTIVITY 13 198 0.0003038 0.001272
1112 ACTIVATION OF IMMUNE RESPONSE 21 427 0.000307 0.001284
1113 SIGNAL RELEASE 12 173 0.0003122 0.001305
1114 EPIDERMIS MORPHOGENESIS 5 29 0.0003159 0.001315
1115 RESPONSE TO PAIN 5 29 0.0003159 0.001315
1116 PIGMENT CELL DIFFERENTIATION 5 29 0.0003159 0.001315
1117 POSITIVE REGULATION OF NUCLEAR DIVISION 7 62 0.000316 0.001315
1118 POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 5 29 0.0003159 0.001315
1119 ALPHA BETA T CELL DIFFERENTIATION 6 45 0.0003413 0.001418
1120 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 6 45 0.0003413 0.001418
1121 NEUROEPITHELIAL CELL DIFFERENTIATION 7 63 0.0003491 0.001448
1122 RESPONSE TO OSMOTIC STRESS 7 63 0.0003491 0.001448
1123 NEGATIVE REGULATION OF MULTI ORGANISM PROCESS 11 151 0.000363 0.001504
1124 MONOSACCHARIDE METABOLIC PROCESS 13 202 0.0003684 0.001525
1125 NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 17 0.0003706 0.001526
1126 POSITIVE REGULATION OF STEROL TRANSPORT 4 17 0.0003706 0.001526
1127 REGULATION OF ENERGY HOMEOSTASIS 4 17 0.0003706 0.001526
1128 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 4 17 0.0003706 0.001526
1129 NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 4 17 0.0003706 0.001526
1130 POSITIVE REGULATION OF CHOLESTEROL TRANSPORT 4 17 0.0003706 0.001526
1131 CEREBELLAR CORTEX MORPHOGENESIS 5 30 0.0003725 0.001531
1132 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 5 30 0.0003725 0.001531
1133 REGULATION OF INTERLEUKIN 10 PRODUCTION 6 46 0.0003857 0.00158
1134 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 7 64 0.000385 0.00158
1135 NEGATIVE REGULATION OF CYTOKINE SECRETION 6 46 0.0003857 0.00158
1136 POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 7 64 0.000385 0.00158
1137 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 8 84 0.0003891 0.001593
1138 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 9 106 0.0004043 0.001653
1139 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 11 153 0.0004062 0.001659
1140 REGULATION OF CAMP METABOLIC PROCESS 10 129 0.0004074 0.001663
1141 PALATE DEVELOPMENT 8 85 0.0004218 0.00172
1142 MUSCLE FIBER DEVELOPMENT 6 47 0.0004343 0.001765
1143 POSITIVE REGULATION OF DEPHOSPHORYLATION 6 47 0.0004343 0.001765
1144 PRIMARY ALCOHOL METABOLIC PROCESS 6 47 0.0004343 0.001765
1145 POSITIVE REGULATION OF GLIOGENESIS 6 47 0.0004343 0.001765
1146 HYALURONAN METABOLIC PROCESS 5 31 0.0004366 0.001768
1147 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 5 31 0.0004366 0.001768
1148 POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 5 31 0.0004366 0.001768
1149 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 5 31 0.0004366 0.001768
1150 ALCOHOL METABOLIC PROCESS 18 348 0.0004514 0.001826
1151 PIGMENTATION 8 86 0.0004567 0.001846
1152 RETINA DEVELOPMENT IN CAMERA TYPE EYE 10 131 0.0004605 0.00186
1153 VIRAL LIFE CYCLE 16 290 0.0004611 0.001861
1154 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 4 18 0.0004686 0.00187
1155 ORGAN MATURATION 4 18 0.0004686 0.00187
1156 GLANDULAR EPITHELIAL CELL DEVELOPMENT 4 18 0.0004686 0.00187
1157 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 4 18 0.0004686 0.00187
1158 MESODERM MORPHOGENESIS 7 66 0.0004656 0.00187
1159 PERICARDIUM DEVELOPMENT 4 18 0.0004686 0.00187
1160 OSTEOBLAST DEVELOPMENT 4 18 0.0004686 0.00187
1161 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 7 66 0.0004656 0.00187
1162 NOTOCHORD DEVELOPMENT 4 18 0.0004686 0.00187
1163 MUSCLE CELL MIGRATION 4 18 0.0004686 0.00187
1164 POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 4 18 0.0004686 0.00187
1165 RESPONSE TO WATER 4 18 0.0004686 0.00187
1166 UTERUS DEVELOPMENT 4 18 0.0004686 0.00187
1167 LOCOMOTORY BEHAVIOR 12 181 0.0004704 0.001876
1168 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 15 263 0.000488 0.001939
1169 NEGATIVE REGULATION OF COAGULATION 6 48 0.0004877 0.001939
1170 MYOFIBRIL ASSEMBLY 6 48 0.0004877 0.001939
1171 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 6 48 0.0004877 0.001939
1172 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 9 109 0.0004967 0.00197
1173 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 9 109 0.0004967 0.00197
1174 NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 5 32 0.0005085 0.002009
1175 POSITIVE REGULATION OF VASODILATION 5 32 0.0005085 0.002009
1176 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 5 32 0.0005085 0.002009
1177 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 5 32 0.0005085 0.002009
1178 PEPTIDE HORMONE PROCESSING 5 32 0.0005085 0.002009
1179 REGULATION OF NOTCH SIGNALING PATHWAY 7 67 0.0005107 0.002012
1180 CELL AGING 7 67 0.0005107 0.002012
1181 CELLULAR RESPONSE TO DRUG 7 67 0.0005107 0.002012
1182 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 17 323 0.0005303 0.002088
1183 LEUKOCYTE PROLIFERATION 8 88 0.0005334 0.002096
1184 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 88 0.0005334 0.002096
1185 NEGATIVE REGULATION OF PEPTIDE SECRETION 6 49 0.000546 0.002139
1186 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 6 49 0.000546 0.002139
1187 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 6 49 0.000546 0.002139
1188 REGULATION OF ATP METABOLIC PROCESS 6 49 0.000546 0.002139
1189 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 10 134 0.0005507 0.002155
1190 REGULATION OF ALPHA BETA T CELL ACTIVATION 7 68 0.0005591 0.002181
1191 REGULATION OF CELL JUNCTION ASSEMBLY 7 68 0.0005591 0.002181
1192 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 7 68 0.0005591 0.002181
1193 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 7 68 0.0005591 0.002181
1194 ADULT BEHAVIOR 10 135 0.0005838 0.002268
1195 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.0005838 0.002268
1196 FIBRIL ORGANIZATION 4 19 0.0005838 0.002268
1197 NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 4 19 0.0005838 0.002268
1198 CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES 4 19 0.0005838 0.002268
1199 NEGATIVE REGULATION OF ANION TRANSPORT 5 33 0.0005891 0.002286
1200 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 7 69 0.0006112 0.002368
1201 POSITIVE REGULATION OF AXONOGENESIS 7 69 0.0006112 0.002368
1202 EYE MORPHOGENESIS 10 136 0.0006186 0.002395
1203 REGULATION OF GLIOGENESIS 8 90 0.0006203 0.002399
1204 CYTOKINE MEDIATED SIGNALING PATHWAY 21 452 0.0006455 0.002495
1205 CELLULAR RESPONSE TO RADIATION 10 137 0.0006551 0.00253
1206 MUSCLE ORGAN MORPHOGENESIS 7 70 0.000667 0.002573
1207 POSITIVE REGULATION OF LIPID TRANSPORT 6 51 0.0006788 0.002602
1208 CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 34 0.0006789 0.002602
1209 RESPONSE TO NICOTINE 6 51 0.0006788 0.002602
1210 NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 6 51 0.0006788 0.002602
1211 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 34 0.0006789 0.002602
1212 OLIGODENDROCYTE DEVELOPMENT 5 34 0.0006789 0.002602
1213 CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS 6 51 0.0006788 0.002602
1214 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 6 51 0.0006788 0.002602
1215 IMMUNE EFFECTOR PROCESS 22 486 0.000683 0.002615
1216 REGULATION OF ANION TRANSPORT 10 138 0.0006933 0.002653
1217 HYDROGEN PEROXIDE CATABOLIC PROCESS 4 20 0.0007177 0.002724
1218 REGULATION OF CHOLESTEROL EFFLUX 4 20 0.0007177 0.002724
1219 REGULATION OF URINE VOLUME 4 20 0.0007177 0.002724
1220 TRACHEA DEVELOPMENT 4 20 0.0007177 0.002724
1221 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 20 0.0007177 0.002724
1222 RESPONSE TO VITAMIN A 4 20 0.0007177 0.002724
1223 MEGAKARYOCYTE DIFFERENTIATION 4 20 0.0007177 0.002724
1224 REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT 4 20 0.0007177 0.002724
1225 LYMPH VESSEL DEVELOPMENT 4 20 0.0007177 0.002724
1226 MYELOID DENDRITIC CELL DIFFERENTIATION 4 20 0.0007177 0.002724
1227 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 7 71 0.0007268 0.002754
1228 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING 7 71 0.0007268 0.002754
1229 SINGLE ORGANISM CELLULAR LOCALIZATION 34 898 0.0007287 0.002759
1230 INTERACTION WITH SYMBIONT 6 52 0.0007539 0.002852
1231 NON CANONICAL WNT SIGNALING PATHWAY 10 140 0.0007753 0.00293
1232 NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 5 35 0.0007785 0.002931
1233 BONE REMODELING 5 35 0.0007785 0.002931
1234 REGULATION OF GLYCOGEN METABOLIC PROCESS 5 35 0.0007785 0.002931
1235 RESPONSE TO MINERALOCORTICOID 5 35 0.0007785 0.002931
1236 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 5 35 0.0007785 0.002931
1237 RESPONSE TO FIBROBLAST GROWTH FACTOR 9 116 0.0007809 0.002937
1238 DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 7 72 0.0007907 0.002969
1239 SMOOTHENED SIGNALING PATHWAY 7 72 0.0007907 0.002969
1240 POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS 12 192 0.0007941 0.00298
1241 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 11 166 0.0008051 0.003019
1242 REGULATION OF DNA BIOSYNTHETIC PROCESS 8 94 0.0008283 0.003103
1243 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 6 53 0.0008353 0.003124
1244 SKELETAL MUSCLE CELL DIFFERENTIATION 6 53 0.0008353 0.003124
1245 REGULATION OF HEART CONTRACTION 13 221 0.0008582 0.003207
1246 REGULATION OF PLASMA MEMBRANE ORGANIZATION 7 73 0.000859 0.003208
1247 RESPONSE TO DIETARY EXCESS 4 21 0.0008719 0.003235
1248 DECIDUALIZATION 4 21 0.0008719 0.003235
1249 LEFT RIGHT PATTERN FORMATION 4 21 0.0008719 0.003235
1250 POSITIVE T CELL SELECTION 4 21 0.0008719 0.003235
1251 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 4 21 0.0008719 0.003235
1252 NEGATIVE REGULATION OF PROTEIN ACETYLATION 4 21 0.0008719 0.003235
1253 EPITHELIAL STRUCTURE MAINTENANCE 4 21 0.0008719 0.003235
1254 RESPONSE TO NITRIC OXIDE 4 21 0.0008719 0.003235
1255 REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 5 36 0.0008886 0.003284
1256 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 95 0.0008882 0.003284
1257 POSITIVE REGULATION OF PROTEIN ACETYLATION 5 36 0.0008886 0.003284
1258 REGULATION OF AXONOGENESIS 11 168 0.0008886 0.003284
1259 HEAD MORPHOGENESIS 5 36 0.0008886 0.003284
1260 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 10 143 0.0009131 0.003372
1261 VENTRICULAR SEPTUM DEVELOPMENT 6 54 0.0009232 0.003407
1262 RESPONSE TO LIGHT STIMULUS 15 280 0.0009279 0.003421
1263 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 74 0.0009319 0.003433
1264 NEUROLOGICAL SYSTEM PROCESS 43 1242 0.0009363 0.003447
1265 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 9 119 0.0009377 0.003449
1266 REGULATION OF LEUKOCYTE CHEMOTAXIS 8 96 0.0009515 0.003491
1267 FEMALE GAMETE GENERATION 8 96 0.0009515 0.003491
1268 REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 96 0.0009515 0.003491
1269 POSITIVE REGULATION OF B CELL PROLIFERATION 5 37 0.00101 0.003697
1270 CELLULAR GLUCOSE HOMEOSTASIS 7 75 0.00101 0.003697
1271 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 5 37 0.00101 0.003697
1272 REGULATION OF B CELL PROLIFERATION 6 55 0.001018 0.003724
1273 RESPONSE TO IMMOBILIZATION STRESS 4 22 0.001048 0.003816
1274 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 4 22 0.001048 0.003816
1275 REGULATION OF CELLULAR EXTRAVASATION 4 22 0.001048 0.003816
1276 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN 4 22 0.001048 0.003816
1277 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 4 22 0.001048 0.003816
1278 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 4 22 0.001048 0.003816
1279 NEGATIVE REGULATION OF IMMUNE RESPONSE 9 121 0.001056 0.003841
1280 FATTY ACID TRANSPORT 6 56 0.00112 0.004073
1281 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 5 38 0.001143 0.004149
1282 CYTOKINE SECRETION 5 38 0.001143 0.004149
1283 ACTOMYOSIN STRUCTURE ORGANIZATION 7 77 0.00118 0.00428
1284 REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 10 148 0.001187 0.004295
1285 POSITIVE REGULATION OF MITOTIC CELL CYCLE 9 123 0.001186 0.004295
1286 POSITIVE REGULATION OF CELL GROWTH 10 148 0.001187 0.004295
1287 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 57 0.00123 0.004445
1288 MYOTUBE DIFFERENTIATION 6 57 0.00123 0.004445
1289 REGULATION OF GLUCOSE TRANSPORT 8 100 0.001242 0.004482
1290 PROSTATE GLAND MORPHOGENESIS 4 23 0.001248 0.004487
1291 RESPONSE TO MAGNESIUM ION 4 23 0.001248 0.004487
1292 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 4 23 0.001248 0.004487
1293 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 4 23 0.001248 0.004487
1294 REGULATION OF SUPEROXIDE METABOLIC PROCESS 4 23 0.001248 0.004487
1295 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 78 0.001273 0.004572
1296 SOMITE DEVELOPMENT 7 78 0.001273 0.004572
1297 NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 5 39 0.001289 0.00462
1298 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 5 39 0.001289 0.00462
1299 REGULATION OF NLRP3 INFLAMMASOME COMPLEX ASSEMBLY 3 11 0.001347 0.004735
1300 CARDIAC MUSCLE ADAPTATION 3 11 0.001347 0.004735
1301 BONE TRABECULA MORPHOGENESIS 3 11 0.001347 0.004735
1302 PRIMITIVE STREAK FORMATION 3 11 0.001347 0.004735
1303 NEGATIVE REGULATION OF GLYCOLYTIC PROCESS 3 11 0.001347 0.004735
1304 RESPONSE TO GRAVITY 3 11 0.001347 0.004735
1305 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 3 11 0.001347 0.004735
1306 ENDOCARDIUM DEVELOPMENT 3 11 0.001347 0.004735
1307 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 13 232 0.001335 0.004735
1308 LYMPHANGIOGENESIS 3 11 0.001347 0.004735
1309 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 11 0.001347 0.004735
1310 ERYTHROCYTE MATURATION 3 11 0.001347 0.004735
1311 MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 3 11 0.001347 0.004735
1312 MUSCLE ATROPHY 3 11 0.001347 0.004735
1313 BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 3 11 0.001347 0.004735
1314 NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS 3 11 0.001347 0.004735
1315 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 3 11 0.001347 0.004735
1316 NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS 3 11 0.001347 0.004735
1317 ACTIVATION OF INNATE IMMUNE RESPONSE 12 204 0.001341 0.004735
1318 CARDIAC CHAMBER FORMATION 3 11 0.001347 0.004735
1319 CAMERA TYPE EYE MORPHOGENESIS 8 101 0.001324 0.004735
1320 IMMUNOLOGICAL SYNAPSE FORMATION 3 11 0.001347 0.004735
1321 ENDOTHELIAL TUBE MORPHOGENESIS 3 11 0.001347 0.004735
1322 REGULATION OF NECROPTOTIC PROCESS 3 11 0.001347 0.004735
1323 CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 3 11 0.001347 0.004735
1324 CORPUS CALLOSUM DEVELOPMENT 3 11 0.001347 0.004735
1325 REGULATION OF MEIOTIC CELL CYCLE 5 40 0.001448 0.00508
1326 ENDODERMAL CELL DIFFERENTIATION 5 40 0.001448 0.00508
1327 FOCAL ADHESION ASSEMBLY 4 24 0.001473 0.00514
1328 HYPOTHALAMUS DEVELOPMENT 4 24 0.001473 0.00514
1329 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 4 24 0.001473 0.00514
1330 SPINAL CORD PATTERNING 4 24 0.001473 0.00514
1331 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 4 24 0.001473 0.00514
1332 REGULATION OF GLIAL CELL DIFFERENTIATION 6 59 0.001475 0.00514
1333 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 4 24 0.001473 0.00514
1334 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 4 24 0.001473 0.00514
1335 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 6 59 0.001475 0.00514
1336 INSULIN RECEPTOR SIGNALING PATHWAY 7 80 0.001477 0.005145
1337 PALLIUM DEVELOPMENT 10 153 0.001525 0.005306
1338 RESPONSE TO STARVATION 10 154 0.001601 0.005566
1339 REGULATION OF SMOOTH MUSCLE CONTRACTION 6 60 0.00161 0.005595
1340 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 5 41 0.001621 0.005607
1341 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 5 41 0.001621 0.005607
1342 CELLULAR RESPONSE TO ESTROGEN STIMULUS 5 41 0.001621 0.005607
1343 MONOCYTE CHEMOTAXIS 5 41 0.001621 0.005607
1344 REGULATION OF LEUKOCYTE DEGRANULATION 5 41 0.001621 0.005607
1345 DEFENSE RESPONSE TO BACTERIUM 13 237 0.001616 0.005607
1346 REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 11 181 0.001623 0.005612
1347 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 7 82 0.001706 0.005893
1348 LENS FIBER CELL DIFFERENTIATION 4 25 0.001724 0.005926
1349 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 4 25 0.001724 0.005926
1350 POSITIVE REGULATION OF COAGULATION 4 25 0.001724 0.005926
1351 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 4 25 0.001724 0.005926
1352 PROTEIN LOCALIZATION TO ORGANELLE 23 556 0.001718 0.005926
1353 THYROID GLAND DEVELOPMENT 4 25 0.001724 0.005926
1354 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 4 25 0.001724 0.005926
1355 REGULATION OF REGULATED SECRETORY PATHWAY 9 130 0.001745 0.005991
1356 REGULATION OF TIMING OF CELL DIFFERENTIATION 3 12 0.001769 0.006011
1357 ANATOMICAL STRUCTURE REGRESSION 3 12 0.001769 0.006011
1358 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 0.001769 0.006011
1359 CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 3 12 0.001769 0.006011
1360 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 3 12 0.001769 0.006011
1361 I KAPPAB PHOSPHORYLATION 3 12 0.001769 0.006011
1362 REGULATION OF DEVELOPMENT HETEROCHRONIC 3 12 0.001769 0.006011
1363 RENAL ABSORPTION 3 12 0.001769 0.006011
1364 COLLECTING DUCT DEVELOPMENT 3 12 0.001769 0.006011
1365 POSITIVE REGULATION OF STEM CELL PROLIFERATION 6 61 0.001755 0.006011
1366 POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 3 12 0.001769 0.006011
1367 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 3 12 0.001769 0.006011
1368 REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 3 12 0.001769 0.006011
1369 POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 12 0.001769 0.006011
1370 POLYSACCHARIDE BIOSYNTHETIC PROCESS 5 42 0.001808 0.006138
1371 REGULATION OF BONE REMODELING 5 42 0.001808 0.006138
1372 LEARNING 9 131 0.001839 0.006238
1373 POSITIVE REGULATION OF MULTI ORGANISM PROCESS 10 157 0.001847 0.006261
1374 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 6 62 0.001909 0.006455
1375 CARDIAC VENTRICLE MORPHOGENESIS 6 62 0.001909 0.006455
1376 REGULATION OF SMOOTHENED SIGNALING PATHWAY 6 62 0.001909 0.006455
1377 REGULATION OF SEQUESTERING OF CALCIUM ION 8 107 0.001916 0.006474
1378 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 7 84 0.001961 0.006621
1379 REGULATION OF T HELPER CELL DIFFERENTIATION 4 26 0.002004 0.006724
1380 REGULATION OF MESONEPHROS DEVELOPMENT 4 26 0.002004 0.006724
1381 NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 4 26 0.002004 0.006724
1382 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 4 26 0.002004 0.006724
1383 MESODERMAL CELL DIFFERENTIATION 4 26 0.002004 0.006724
1384 SCHWANN CELL DEVELOPMENT 4 26 0.002004 0.006724
1385 INACTIVATION OF MAPK ACTIVITY 4 26 0.002004 0.006724
1386 MYELOID DENDRITIC CELL ACTIVATION 4 26 0.002004 0.006724
1387 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 4 26 0.002004 0.006724
1388 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 5 43 0.002012 0.006744
1389 REGULATION OF EXOCYTOSIS 11 186 0.002014 0.006745
1390 REGULATION OF CELL CYCLE ARREST 8 108 0.002032 0.006802
1391 REGULATION OF EPIDERMIS DEVELOPMENT 6 63 0.002073 0.006929
1392 POSITIVE REGULATION OF JUN KINASE ACTIVITY 6 63 0.002073 0.006929
1393 TOLL LIKE RECEPTOR SIGNALING PATHWAY 7 85 0.002099 0.007006
1394 EPHRIN RECEPTOR SIGNALING PATHWAY 7 85 0.002099 0.007006
1395 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 8 109 0.002154 0.007173
1396 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 8 109 0.002154 0.007173
1397 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 8 109 0.002154 0.007173
1398 NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 5 44 0.002231 0.007415
1399 POSITIVE REGULATION OF MUSCLE CONTRACTION 5 44 0.002231 0.007415
1400 NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 5 44 0.002231 0.007415
1401 REGULATION OF VASCULOGENESIS 3 13 0.002264 0.007417
1402 NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 3 13 0.002264 0.007417
1403 MALE SEX DETERMINATION 3 13 0.002264 0.007417
1404 WHITE FAT CELL DIFFERENTIATION 3 13 0.002264 0.007417
1405 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 3 13 0.002264 0.007417
1406 SPONGIOTROPHOBLAST LAYER DEVELOPMENT 3 13 0.002264 0.007417
1407 BEHAVIORAL RESPONSE TO PAIN 3 13 0.002264 0.007417
1408 RESPONSE TO INACTIVITY 3 13 0.002264 0.007417
1409 EYELID DEVELOPMENT IN CAMERA TYPE EYE 3 13 0.002264 0.007417
1410 HEMATOPOIETIC STEM CELL PROLIFERATION 3 13 0.002264 0.007417
1411 REGULATION OF HEART RATE 7 86 0.002245 0.007417
1412 HEART VALVE FORMATION 3 13 0.002264 0.007417
1413 REGULATION OF NEUROTRANSMITTER TRANSPORT 6 64 0.002248 0.007417
1414 NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION 3 13 0.002264 0.007417
1415 NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 3 13 0.002264 0.007417
1416 REGULATION OF CHOLESTEROL STORAGE 3 13 0.002264 0.007417
1417 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 3 13 0.002264 0.007417
1418 REGULATION OF CELL FATE SPECIFICATION 3 13 0.002264 0.007417
1419 NEGATIVE REGULATION OF GLUCONEOGENESIS 3 13 0.002264 0.007417
1420 REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 3 13 0.002264 0.007417
1421 SKELETAL MUSCLE TISSUE REGENERATION 4 27 0.002314 0.007536
1422 DEVELOPMENTAL INDUCTION 4 27 0.002314 0.007536
1423 REGULATION OF ASTROCYTE DIFFERENTIATION 4 27 0.002314 0.007536
1424 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 27 0.002314 0.007536
1425 DETECTION OF BIOTIC STIMULUS 4 27 0.002314 0.007536
1426 LIPID STORAGE 4 27 0.002314 0.007536
1427 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 27 0.002314 0.007536
1428 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 4 27 0.002314 0.007536
1429 FLUID TRANSPORT 4 27 0.002314 0.007536
1430 INTRACELLULAR PROTEIN TRANSPORT 29 781 0.00235 0.007647
1431 REGULATION OF NEUROTRANSMITTER LEVELS 11 190 0.002378 0.007732
1432 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 8 111 0.002414 0.007843
1433 REGULATION OF RESPONSE TO OXIDATIVE STRESS 6 65 0.002433 0.0079
1434 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 5 45 0.002467 0.007977
1435 THYMOCYTE AGGREGATION 5 45 0.002467 0.007977
1436 T CELL DIFFERENTIATION IN THYMUS 5 45 0.002467 0.007977
1437 REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS 5 45 0.002467 0.007977
1438 ENDOCHONDRAL BONE MORPHOGENESIS 5 45 0.002467 0.007977
1439 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 45 0.002467 0.007977
1440 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 14 280 0.002573 0.008312
1441 PROTEIN AUTOPHOSPHORYLATION 11 192 0.002579 0.008328
1442 SOMATIC STEM CELL POPULATION MAINTENANCE 6 66 0.00263 0.00848
1443 LENS DEVELOPMENT IN CAMERA TYPE EYE 6 66 0.00263 0.00848
1444 REGULATION OF MEMBRANE POTENTIAL 16 343 0.002644 0.008519
1445 VENTRICULAR SEPTUM MORPHOGENESIS 4 28 0.002656 0.008522
1446 REGULATION OF FIBROBLAST MIGRATION 4 28 0.002656 0.008522
1447 NEGATIVE REGULATION OF EXOCYTOSIS 4 28 0.002656 0.008522
1448 NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY 4 28 0.002656 0.008522
1449 RESPONSE TO GONADOTROPIN 4 28 0.002656 0.008522
1450 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 0.002656 0.008522
1451 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 11 193 0.002685 0.008609
1452 CEREBELLAR CORTEX DEVELOPMENT 5 46 0.002721 0.008713
1453 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 5 46 0.002721 0.008713
1454 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 7 89 0.002728 0.008731
1455 AMINOGLYCAN METABOLIC PROCESS 10 166 0.002777 0.008882
1456 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN 3 14 0.002836 0.008972
1457 POSITIVE REGULATION OF NEURON DEATH 6 67 0.002838 0.008972
1458 MACROMOLECULE DEACYLATION 6 67 0.002838 0.008972
1459 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 3 14 0.002836 0.008972
1460 POSITIVE REGULATION OF HISTONE DEACETYLATION 3 14 0.002836 0.008972
1461 EPITHELIAL CELL CELL ADHESION 3 14 0.002836 0.008972
1462 ETHANOL METABOLIC PROCESS 3 14 0.002836 0.008972
1463 POSITIVE REGULATION OF P38MAPK CASCADE 3 14 0.002836 0.008972
1464 RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE 3 14 0.002836 0.008972
1465 POSITIVE REGULATION OF RENAL SODIUM EXCRETION 3 14 0.002836 0.008972
1466 REGULATION OF MONOCYTE DIFFERENTIATION 3 14 0.002836 0.008972
1467 CONVERGENT EXTENSION 3 14 0.002836 0.008972
1468 NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 3 14 0.002836 0.008972
1469 CELLULAR RESPONSE TO VITAMIN D 3 14 0.002836 0.008972
1470 REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 3 14 0.002836 0.008972
1471 BONE MATURATION 3 14 0.002836 0.008972
1472 REGULATION OF HISTONE H3 K9 ACETYLATION 3 14 0.002836 0.008972
1473 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 5 47 0.002993 0.009455
1474 REGULATION OF MEIOTIC NUCLEAR DIVISION 4 29 0.00303 0.009533
1475 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 4 29 0.00303 0.009533
1476 STEM CELL DIVISION 4 29 0.00303 0.009533
1477 REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS 4 29 0.00303 0.009533
1478 REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 4 29 0.00303 0.009533
1479 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 10 168 0.003028 0.009533
1480 REGULATION OF PHAGOCYTOSIS 6 68 0.003059 0.009617
1481 PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION 8 116 0.003173 0.009969
1482 EPIDERMAL CELL DIFFERENTIATION 9 142 0.003178 0.009979
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 112 1476 3.343e-34 3.106e-31
2 TRANSCRIPTION FACTOR BINDING 59 524 2.543e-26 1.181e-23
3 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 60 629 5.683e-23 1.76e-20
4 REGULATORY REGION NUCLEIC ACID BINDING 65 818 1.47e-20 3.413e-18
5 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 79 1199 6.304e-20 1.171e-17
6 ENZYME BINDING 97 1737 1.906e-19 2.736e-17
7 SEQUENCE SPECIFIC DNA BINDING 72 1037 2.062e-19 2.736e-17
8 MACROMOLECULAR COMPLEX BINDING 85 1399 3.195e-19 3.71e-17
9 IDENTICAL PROTEIN BINDING 78 1209 3.92e-19 4.046e-17
10 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 38 315 2.998e-18 2.785e-16
11 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 37 328 7.901e-17 6.672e-15
12 DOUBLE STRANDED DNA BINDING 56 764 3.244e-16 2.511e-14
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 30 226 8.7e-16 6.217e-14
14 PROTEIN DIMERIZATION ACTIVITY 68 1149 7.921e-15 5.256e-13
15 GROWTH FACTOR BINDING 21 123 1.291e-13 7.993e-12
16 GROWTH FACTOR ACTIVITY 23 160 3.868e-13 2.246e-11
17 KINASE BINDING 43 606 3.468e-12 1.79e-10
18 CORE PROMOTER PROXIMAL REGION DNA BINDING 33 371 3.343e-12 1.79e-10
19 PROTEIN COMPLEX BINDING 55 935 5.166e-12 2.526e-10
20 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 16 81 1.077e-11 5.004e-10
21 PROTEIN TYROSINE KINASE ACTIVITY 22 176 2.183e-11 9.657e-10
22 INTEGRIN BINDING 17 105 6.83e-11 2.759e-09
23 CELL ADHESION MOLECULE BINDING 22 186 6.554e-11 2.759e-09
24 PROTEIN HOMODIMERIZATION ACTIVITY 45 722 8.217e-11 3.181e-09
25 REPRESSING TRANSCRIPTION FACTOR BINDING 13 57 1.401e-10 5.205e-09
26 CYTOKINE RECEPTOR BINDING 24 271 3.525e-09 1.26e-07
27 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 15 104 4.764e-09 1.639e-07
28 HISTONE DEACETYLASE BINDING 15 105 5.452e-09 1.762e-07
29 MOLECULAR FUNCTION REGULATOR 62 1353 5.5e-09 1.762e-07
30 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 14 90 5.707e-09 1.767e-07
31 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 12 64 7.913e-09 2.371e-07
32 CHROMATIN BINDING 30 435 1.421e-08 4.125e-07
33 GLYCOSAMINOGLYCAN BINDING 19 205 7.468e-08 2.041e-06
34 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 10 50 7.437e-08 2.041e-06
35 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 34 588 1.158e-07 3.073e-06
36 CORE PROMOTER BINDING 16 152 1.405e-07 3.626e-06
37 G PROTEIN COUPLED RECEPTOR BINDING 21 259 1.538e-07 3.862e-06
38 GLYCOPROTEIN BINDING 13 101 2.018e-07 4.934e-06
39 CYTOKINE ACTIVITY 19 219 2.118e-07 5.044e-06
40 PROTEIN KINASE ACTIVITY 35 640 2.851e-07 6.621e-06
41 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 16 168 5.557e-07 1.259e-05
42 INSULIN LIKE GROWTH FACTOR BINDING 7 25 6.035e-07 1.335e-05
43 PROTEIN HETERODIMERIZATION ACTIVITY 28 468 8.016e-07 1.732e-05
44 ENZYME REGULATOR ACTIVITY 44 959 1.091e-06 2.303e-05
45 HEPARIN BINDING 15 157 1.205e-06 2.488e-05
46 RECEPTOR ACTIVITY 64 1649 1.304e-06 2.633e-05
47 HISTONE ACETYLTRANSFERASE BINDING 7 28 1.408e-06 2.782e-05
48 BETA CATENIN BINDING 11 84 1.476e-06 2.856e-05
49 CALCIUM ION BINDING 35 697 2.033e-06 3.855e-05
50 SMAD BINDING 10 72 2.57e-06 4.681e-05
51 SULFUR COMPOUND BINDING 18 234 2.531e-06 4.681e-05
52 TAU PROTEIN BINDING 5 12 2.83e-06 5.056e-05
53 GROWTH FACTOR RECEPTOR BINDING 13 129 3.42e-06 5.994e-05
54 CYTOSKELETAL PROTEIN BINDING 38 819 4.752e-06 8.119e-05
55 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 13 133 4.807e-06 8.119e-05
56 KINASE ACTIVITY 38 842 8.946e-06 0.0001484
57 KINASE REGULATOR ACTIVITY 15 186 9.834e-06 0.0001603
58 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 9 70 1.557e-05 0.0002493
59 RNA POLYMERASE II REPRESSING TRANSCRIPTION FACTOR BINDING 6 27 1.708e-05 0.0002689
60 ENZYME INHIBITOR ACTIVITY 22 378 1.881e-05 0.0002912
61 NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY 5 17 2.027e-05 0.0003086
62 STRUCTURAL MOLECULE ACTIVITY 33 732 3.619e-05 0.0005423
63 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 10 101 5.357e-05 0.00079
64 LIPID BINDING 30 657 6.529e-05 0.0009477
65 PROTEASE BINDING 10 104 6.882e-05 0.0009688
66 E BOX BINDING 6 34 6.851e-05 0.0009688
67 WNT ACTIVATED RECEPTOR ACTIVITY 5 22 7.907e-05 0.001096
68 CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 4 12 8.38e-05 0.001128
69 HISTONE DEACETYLASE ACTIVITY H3 K14 SPECIFIC 4 12 8.38e-05 0.001128
70 R SMAD BINDING 5 23 9.93e-05 0.001318
71 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 228 0.0001045 0.001367
72 KINASE INHIBITOR ACTIVITY 9 89 0.000107 0.001381
73 CYTOKINE BINDING 9 92 0.0001384 0.001762
74 SIGNAL TRANSDUCER ACTIVITY 59 1731 0.0001539 0.001932
75 PROTEIN C TERMINUS BINDING 13 186 0.0001646 0.002012
76 METALLOENDOPEPTIDASE INHIBITOR ACTIVITY 4 14 0.0001639 0.002012
77 PEPTIDASE REGULATOR ACTIVITY 14 214 0.000187 0.002227
78 ACTIVATING TRANSCRIPTION FACTOR BINDING 7 57 0.0001859 0.002227
79 RECEPTOR SERINE THREONINE KINASE BINDING 4 15 0.0002198 0.002581
80 CHEMOATTRACTANT ACTIVITY 5 27 0.0002223 0.002581
81 OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR 6 42 0.0002318 0.002659
82 PROTEIN DEACETYLASE ACTIVITY 6 43 0.0002647 0.002999
83 TRANSFORMING GROWTH FACTOR BETA BINDING 4 16 0.0002882 0.003187
84 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 38 992 0.0002848 0.003187
85 PROTEIN DOMAIN SPECIFIC BINDING 27 624 0.0003549 0.003879
86 PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 5 30 0.0003725 0.003978
87 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 4 17 0.0003706 0.003978
88 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 7 65 0.0004238 0.004474
89 WNT PROTEIN BINDING 5 31 0.0004366 0.004557
90 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 8 86 0.0004567 0.004714
91 NOTCH BINDING 4 18 0.0004686 0.004784
92 TETRAPYRROLE BINDING 10 134 0.0005507 0.005561
93 ENDOPEPTIDASE ACTIVITY 21 448 0.0005758 0.005692
94 TRANSCRIPTION COACTIVATOR ACTIVITY 16 296 0.0005759 0.005692
95 PROTEIN KINASE C BINDING 6 50 0.0006096 0.005961
96 SERINE HYDROLASE ACTIVITY 14 242 0.0006481 0.006271
97 STEROID BINDING 8 91 0.0006678 0.006331
98 ANTIOXIDANT ACTIVITY 7 70 0.000667 0.006331
99 EXTRACELLULAR MATRIX BINDING 6 51 0.0006788 0.00637
100 ACTIN BINDING 19 393 0.0007205 0.006693
101 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 6 53 0.0008353 0.007683
102 FRIZZLED BINDING 5 36 0.0008886 0.008093
103 HORMONE ACTIVITY 9 119 0.0009377 0.008376
104 SIGNALING RECEPTOR ACTIVITY 47 1393 0.0009343 0.008376
105 DEACETYLASE ACTIVITY 6 55 0.001018 0.009008
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR SPACE 100 1376 8.941e-29 5.222e-26
2 CELL SURFACE 66 757 4.622e-23 1.35e-20
3 EXTRACELLULAR MATRIX 48 426 1.568e-21 3.052e-19
4 ANCHORING JUNCTION 49 489 9.065e-20 1.324e-17
5 CELL SUBSTRATE JUNCTION 42 398 6.848e-18 7.999e-16
6 PROTEINACEOUS EXTRACELLULAR MATRIX 38 356 1.894e-16 1.844e-14
7 CELL JUNCTION 69 1151 2.563e-15 2.139e-13
8 CELL PROJECTION 87 1786 7.186e-14 5.246e-12
9 INTRINSIC COMPONENT OF PLASMA MEMBRANE 80 1649 1.138e-12 7.384e-11
10 TRANSCRIPTION FACTOR COMPLEX 30 298 1.445e-12 7.84e-11
11 MEMBRANE REGION 63 1134 1.477e-12 7.84e-11
12 INTRACELLULAR VESICLE 66 1259 5.428e-12 2.642e-10
13 SIDE OF MEMBRANE 33 428 1.525e-10 6.852e-09
14 EXTERNAL SIDE OF PLASMA MEMBRANE 24 238 2.542e-10 1.06e-08
15 PLASMA MEMBRANE REGION 51 929 3.851e-10 1.499e-08
16 MEMBRANE MICRODOMAIN 26 288 5.127e-10 1.871e-08
17 NEURON PROJECTION 51 942 6.231e-10 2.141e-08
18 CELL BODY 33 494 5.777e-09 1.874e-07
19 NEURON PART 59 1265 7.172e-09 2.103e-07
20 RECEPTOR COMPLEX 26 327 7.564e-09 2.103e-07
21 CELL LEADING EDGE 27 350 7.394e-09 2.103e-07
22 SECRETORY GRANULE 27 352 8.347e-09 2.216e-07
23 CELL CELL JUNCTION 28 383 1.254e-08 3.184e-07
24 CELL PROJECTION PART 47 946 4.437e-08 1.08e-06
25 PLATELET ALPHA GRANULE 12 75 5.108e-08 1.126e-06
26 SECRETORY VESICLE 30 461 5.207e-08 1.126e-06
27 VESICLE LUMEN 14 106 4.916e-08 1.126e-06
28 EXTRACELLULAR MATRIX COMPONENT 15 125 6.054e-08 1.263e-06
29 CYTOPLASMIC VESICLE PART 35 601 6.29e-08 1.267e-06
30 APICAL JUNCTION COMPLEX 15 128 8.334e-08 1.622e-06
31 BASAL PART OF CELL 10 51 9.079e-08 1.71e-06
32 ENDOCYTIC VESICLE 21 256 1.263e-07 2.306e-06
33 SOMATODENDRITIC COMPARTMENT 36 650 1.405e-07 2.487e-06
34 PLASMA MEMBRANE RECEPTOR COMPLEX 17 175 1.85e-07 3.178e-06
35 BASAL PLASMA MEMBRANE 8 33 3.157e-07 5.268e-06
36 BASEMENT MEMBRANE 12 93 5.79e-07 9.393e-06
37 ACTOMYOSIN 10 62 6.215e-07 9.809e-06
38 PERINUCLEAR REGION OF CYTOPLASM 34 642 8.802e-07 1.353e-05
39 CELL PROJECTION MEMBRANE 21 298 1.542e-06 2.31e-05
40 SECRETORY GRANULE LUMEN 11 85 1.664e-06 2.429e-05
41 PLATELET ALPHA GRANULE LUMEN 9 55 2.01e-06 2.864e-05
42 BASOLATERAL PLASMA MEMBRANE 17 211 2.567e-06 3.57e-05
43 ACTIN CYTOSKELETON 26 444 2.952e-06 4.01e-05
44 LAMELLIPODIUM 15 172 3.783e-06 5.022e-05
45 LATERAL PLASMA MEMBRANE 8 50 8.928e-06 0.0001159
46 APICAL PLASMA MEMBRANE 19 292 1.511e-05 0.0001918
47 VACUOLE 47 1180 2.029e-05 0.0002522
48 ACTIN FILAMENT BUNDLE 8 57 2.417e-05 0.000294
49 RUFFLE 13 156 2.71e-05 0.0003229
50 APICAL PART OF CELL 21 361 2.925e-05 0.0003417
51 SECRETORY GRANULE MEMBRANE 9 78 3.764e-05 0.000431
52 NUCLEAR CHROMATIN 18 291 4.908e-05 0.0005512
53 GOLGI APPARATUS 53 1445 5.468e-05 0.0006025
54 LYTIC VACUOLE 26 526 5.593e-05 0.0006048
55 PLATELET ALPHA GRANULE MEMBRANE 4 13 0.000119 0.001264
56 LEADING EDGE MEMBRANE 11 134 0.0001277 0.001332
57 CELL CORTEX 15 238 0.0001678 0.001719
58 BLOOD MICROPARTICLE 11 143 0.0002267 0.002244
59 PLASMA MEMBRANE PROTEIN COMPLEX 24 510 0.0002248 0.002244
60 RUFFLE MEMBRANE 8 80 0.0002783 0.002709
61 ENDOCYTIC VESICLE LUMEN 4 17 0.0003706 0.003548
62 CYTOPLASMIC REGION 16 287 0.0004115 0.003876
63 PLASMA MEMBRANE RAFT 8 86 0.0004567 0.004233
64 CHROMATIN 21 441 0.0004695 0.004284
65 CLATHRIN COATED VESICLE 11 157 0.0005056 0.004542
66 T CELL RECEPTOR COMPLEX 4 19 0.0005838 0.005165
67 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 10 136 0.0006186 0.005388
68 DENDRITE 21 451 0.0006274 0.005388
69 VACUOLAR PART 28 694 0.0008275 0.007004
70 MICROVILLUS 7 75 0.00101 0.008423

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04514_Cell_adhesion_molecules_.CAMs. 23 136 1.072e-14 1.897e-12
2 hsa04380_Osteoclast_differentiation 20 128 2.772e-12 2.453e-10
3 hsa04010_MAPK_signaling_pathway 27 268 1.925e-11 1.136e-09
4 hsa04510_Focal_adhesion 23 200 4.278e-11 1.893e-09
5 hsa04350_TGF.beta_signaling_pathway 15 85 2.585e-10 9.151e-09
6 hsa04670_Leukocyte_transendothelial_migration 16 117 3.232e-09 9.535e-08
7 hsa04920_Adipocytokine_signaling_pathway 11 68 1.647e-07 4.079e-06
8 hsa04630_Jak.STAT_signaling_pathway 16 155 1.843e-07 4.079e-06
9 hsa04340_Hedgehog_signaling_pathway 10 56 2.303e-07 4.53e-06
10 hsa04640_Hematopoietic_cell_lineage 12 88 3.138e-07 5.555e-06
11 hsa04330_Notch_signaling_pathway 9 47 5e-07 8.045e-06
12 hsa04310_Wnt_signaling_pathway 15 151 7.322e-07 1.08e-05
13 hsa04530_Tight_junction 14 133 8.501e-07 1.158e-05
14 hsa04916_Melanogenesis 12 101 1.424e-06 1.8e-05
15 hsa04620_Toll.like_receptor_signaling_pathway 11 102 1.009e-05 0.000119
16 hsa04512_ECM.receptor_interaction 10 85 1.176e-05 0.0001301
17 hsa04660_T_cell_receptor_signaling_pathway 11 108 1.745e-05 0.0001817
18 hsa04320_Dorso.ventral_axis_formation 5 25 0.0001514 0.001489
19 hsa04360_Axon_guidance 10 130 0.0004333 0.004036
20 hsa04810_Regulation_of_actin_cytoskeleton 13 214 0.0006365 0.005633
21 hsa04150_mTOR_signaling_pathway 6 52 0.0007539 0.006354
22 hsa04520_Adherens_junction 7 73 0.000859 0.006911
23 hsa04370_VEGF_signaling_pathway 7 76 0.001092 0.008405
24 hsa04621_NOD.like_receptor_signaling_pathway 6 59 0.001475 0.01088
25 hsa04110_Cell_cycle 9 128 0.001567 0.01109
26 hsa03320_PPAR_signaling_pathway 6 70 0.003538 0.02357
27 hsa04672_Intestinal_immune_network_for_IgA_production 5 49 0.003596 0.02357
28 hsa04662_B_cell_receptor_signaling_pathway 6 75 0.004978 0.03086
29 hsa04614_Renin.angiotensin_system 3 17 0.005056 0.03086
30 hsa04722_Neurotrophin_signaling_pathway 8 127 0.00549 0.0314
31 hsa04912_GnRH_signaling_pathway 7 101 0.0055 0.0314
32 hsa04130_SNARE_interactions_in_vesicular_transport 4 36 0.006696 0.03704
33 hsa04974_Protein_digestion_and_absorption 6 81 0.007226 0.03876
34 hsa04910_Insulin_signaling_pathway 8 138 0.008918 0.04642
35 hsa04012_ErbB_signaling_pathway 6 87 0.01013 0.0498
36 hsa04914_Progesterone.mediated_oocyte_maturation 6 87 0.01013 0.0498
37 hsa04144_Endocytosis 10 203 0.0111 0.05308
38 hsa04062_Chemokine_signaling_pathway 9 189 0.01897 0.08835
39 hsa04664_Fc_epsilon_RI_signaling_pathway 5 79 0.02556 0.116
40 hsa04020_Calcium_signaling_pathway 8 177 0.03413 0.151
41 hsa04210_Apoptosis 5 89 0.03981 0.1719
42 hsa04142_Lysosome 6 121 0.04291 0.1808
43 hsa00830_Retinol_metabolism 4 64 0.04581 0.1886
44 hsa04115_p53_signaling_pathway 4 69 0.05753 0.2263
45 hsa04610_Complement_and_coagulation_cascades 4 69 0.05753 0.2263
46 hsa04730_Long.term_depression 4 70 0.06004 0.231
47 hsa04964_Proximal_tubule_bicarbonate_reclamation 2 23 0.08368 0.3151
48 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 2 26 0.1032 0.3806
49 hsa04623_Cytosolic_DNA.sensing_pathway 3 56 0.1138 0.4111
50 hsa04540_Gap_junction 4 90 0.1219 0.4315
51 hsa00590_Arachidonic_acid_metabolism 3 59 0.1277 0.4431
52 hsa04666_Fc_gamma_R.mediated_phagocytosis 4 95 0.1405 0.4781
53 hsa00010_Glycolysis_._Gluconeogenesis 3 65 0.157 0.5243
54 hsa04972_Pancreatic_secretion 4 101 0.1641 0.5378
55 hsa00565_Ether_lipid_metabolism 2 36 0.1751 0.5635
56 hsa04622_RIG.I.like_receptor_signaling_pathway 3 71 0.1882 0.5844
57 hsa04976_Bile_secretion 3 71 0.1882 0.5844
58 hsa00350_Tyrosine_metabolism 2 41 0.2134 0.6513
59 hsa00380_Tryptophan_metabolism 2 42 0.2212 0.6525
60 hsa04960_Aldosterone.regulated_sodium_reabsorption 2 42 0.2212 0.6525
61 hsa04270_Vascular_smooth_muscle_contraction 4 116 0.2284 0.6533
62 hsa00071_Fatty_acid_metabolism 2 43 0.229 0.6533
63 hsa04145_Phagosome 5 156 0.2325 0.6533
64 hsa04962_Vasopressin.regulated_water_reabsorption 2 44 0.2368 0.6548
65 hsa00514_Other_types_of_O.glycan_biosynthesis 2 46 0.2524 0.6769
66 hsa04975_Fat_digestion_and_absorption 2 46 0.2524 0.6769
67 hsa00510_N.Glycan_biosynthesis 2 49 0.2759 0.7289
68 hsa04970_Salivary_secretion 3 89 0.2887 0.7513
69 hsa03010_Ribosome 3 92 0.3059 0.7848
70 hsa00330_Arginine_and_proline_metabolism 2 54 0.315 0.7964
71 hsa04650_Natural_killer_cell_mediated_cytotoxicity 4 136 0.3216 0.8017
72 hsa04120_Ubiquitin_mediated_proteolysis 4 139 0.3359 0.8258
73 hsa04114_Oocyte_meiosis 3 114 0.4316 0.9667
74 hsa04720_Long.term_potentiation 2 70 0.4352 0.9667
75 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 2 71 0.4424 0.9667
76 hsa00982_Drug_metabolism_._cytochrome_P450 2 73 0.4566 0.9824
77 hsa00564_Glycerophospholipid_metabolism 2 80 0.5045 1
78 hsa00230_Purine_metabolism 2 162 0.8583 1

Quest ID: d3dd0a28559e26dd41a8551d4733a57a